[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 597
1. Zhang L, Smyrk TC, Young WF Jr, Stratakis CA, Carney JA: Gastric stromal tumors in Carney triad are different clinically, pathologically, and behaviorally from sporadic gastric gastrointestinal stromal tumors: findings in 104 cases. Am J Surg Pathol; 2010 Jan;34(1):53-64
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Carney triad, as originally described in 1977, was the association of 3 tumors: gastric epithelioid leiomyosarcoma [later renamed gastrointestinal stromal tumor (GIST)], extra-adrenal paraganglioma, and pulmonary chondroma.
  • [MeSH-minor] Adolescent. Adult. Aged. Child. Female. Humans. Immunohistochemistry. Male. Middle Aged. Risk Factors. Young Adult

  • Genetic Alliance. consumer health - Gastrointestinal Stromal Tumors.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Clin Cancer Res. 2008 Sep 15;14(18):5715-21 [18779314.001]
  • [Cites] Am J Surg Pathol. 2008 Oct;32(10):1553-9 [18724245.001]
  • [Cites] Langenbecks Arch Surg. 2009 Mar;394(2):375-81 [19104826.001]
  • [Cites] Hematol Oncol Clin North Am. 2009 Feb;23(1):49-68, vii-viii [19248970.001]
  • [Cites] J Intern Med. 2009 Jul;266(1):43-52 [19522824.001]
  • [Cites] J Radiol. 2000 Jan;81(1):39-42 [10671723.001]
  • [Cites] Rofo. 2000 Mar;172(3):287-94 [10778462.001]
  • [Cites] Virchows Arch. 2001 Jan;438(1):1-12 [11213830.001]
  • [Cites] Gastroenterology. 2001 Jan;120(1):210-5 [11208730.001]
  • [Cites] N Engl J Med. 2001 Apr 5;344(14):1052-6 [11287975.001]
  • [Cites] J Thorac Cardiovasc Surg. 2001 May;121(5):1011-2 [11326257.001]
  • [Cites] Histopathology. 2001 Oct;39(4):359-63 [11683935.001]
  • [Cites] Am J Med Genet. 2002 Mar 1;108(2):132-9 [11857563.001]
  • [Cites] J Pediatr Hematol Oncol. 2001 Nov;23(8):519-24 [11878780.001]
  • [Cites] Hum Pathol. 2002 May;33(5):459-65 [12094370.001]
  • [Cites] N Engl J Med. 2002 Aug 15;347(7):472-80 [12181401.001]
  • [Cites] Science. 2003 Jan 31;299(5607):708-10 [12522257.001]
  • [Cites] Gastroenterology. 2004 Jan;126(1):318-21 [14699510.001]
  • [Cites] Cancer. 1976 Aug;38(2):708-28 [974992.001]
  • [Cites] N Engl J Med. 1977 Jun 30;296(26):1517-8 [865533.001]
  • [Cites] Cancer. 1979 Jan;43(1):374-82 [367573.001]
  • [Cites] Am J Surg Pathol. 1983 Sep;7(6):507-19 [6625048.001]
  • [Cites] N Engl J Med. 1983 Nov 17;309(20):1210-3 [6633569.001]
  • [Cites] Am J Surg Pathol. 1987 Jun;11(6):464-73 [3035954.001]
  • [Cites] Hum Pathol. 1988 Mar;19(3):257-64 [3126126.001]
  • [Cites] Br J Radiol. 1988 Dec;61(732):1181-4 [3219501.001]
  • [Cites] Am J Physiol. 1989 Oct;257(4 Pt 1):C830-5 [2801932.001]
  • [Cites] Gastroenterology. 1990 May;98(5 Pt 1):1358-65 [2323526.001]
  • [Cites] Ann Surg. 1993 Jan;217(1):72-7 [8424704.001]
  • [Cites] Am J Surg Pathol. 1993 Jul;17(7):706-14 [8317611.001]
  • [Cites] Endoscopy. 1994 Oct;26(8):659-65 [7859674.001]
  • [Cites] Scand J Gastroenterol Suppl. 1995;212:96-9 [8578237.001]
  • [Cites] Science. 1998 Jan 23;279(5350):577-80 [9438854.001]
  • [Cites] Am J Pathol. 1998 May;152(5):1259-69 [9588894.001]
  • [Cites] Eur Respir J. 1998 Jun;11(6):1409-11 [9657587.001]
  • [Cites] Nat Genet. 1998 Aug;19(4):323-4 [9697690.001]
  • [Cites] Med Pediatr Oncol. 1998 Dec;31(6):537-40 [9835913.001]
  • [Cites] Am J Surg Pathol. 1999 Feb;23(2):153-8 [9989841.001]
  • [Cites] Mayo Clin Proc. 1999 Jun;74(6):543-52 [10377927.001]
  • [Cites] Cancer Detect Prev. 1999;23(5):435-43 [10468897.001]
  • [Cites] Am J Surg Pathol. 1999 Sep;23(9):1109-18 [10478672.001]
  • [Cites] J R Soc Med. 2004 Nov;97(11):540-1 [15520151.001]
  • [Cites] Ann Anat Pathol (Paris). 1960 Oct-Dec;5:484-97 [13767359.001]
  • [Cites] Am J Surg Pathol. 2005 Jan;29(1):52-68 [15613856.001]
  • [Cites] Hum Pathol. 2005 Jan;36(1):112-6 [15712189.001]
  • [Cites] Int J Surg Pathol. 2005 Jan;13(1):87-92 [15735861.001]
  • [Cites] J Pediatr Hematol Oncol. 2005 Apr;27(4):179-87 [15838387.001]
  • [Cites] Am J Surg Pathol. 2005 Jun;29(6):755-63 [15897742.001]
  • [Cites] Transplantation. 2005 Jul 27;80(2):283-4 [16041278.001]
  • [Cites] Am J Surg Pathol. 2005 Sep;29(9):1170-6 [16096406.001]
  • [Cites] Am J Surg Pathol. 2005 Oct;29(10):1373-81 [16160481.001]
  • [Cites] Histopathology. 2005 Oct;47(4):438-9 [16178904.001]
  • [Cites] Histopathology. 2006 Jan;48(1):83-96 [16359540.001]
  • [Cites] Medicina (B Aires). 2006;66(1):43-5 [16555728.001]
  • [Cites] Gastroenterology. 2006 Dec;131(6):1907-12 [17087943.001]
  • [Cites] Am J Surg Pathol. 2007 Jan;31(1):113-20 [17197927.001]
  • [Cites] ANZ J Surg. 2007 Jan-Feb;77(1-2):88-90 [17295830.001]
  • [Cites] J Pathol. 2007 Mar;211(4):463-70 [17226762.001]
  • [Cites] Pediatr Hematol Oncol. 2007 Apr-May;24(3):209-19 [17454792.001]
  • [Cites] Am J Surg Pathol. 2007 Jun;31(6):933-7 [17527083.001]
  • [Cites] J Clin Endocrinol Metab. 2007 Aug;92(8):2938-43 [17535989.001]
  • [Cites] N Engl J Med. 2007 Sep 6;357(10):1054-6 [17804857.001]
  • [Cites] Pediatr Blood Cancer. 2008 Feb;50(2):399-401 [17039489.001]
  • [Cites] Am J Surg Pathol. 2008 May;32(5):738-43 [18360281.001]
  • [Cites] Surgeon. 2008 Aug;6(4):249-51 [18697369.001]
  • [Cites] Am J Surg Pathol. 2008 Sep;32(9):1412-20 [18670346.001]
  • (PMID = 19935059.001).
  • [ISSN] 1532-0979
  • [Journal-full-title] The American journal of surgical pathology
  • [ISO-abbreviation] Am. J. Surg. Pathol.
  • [Language] eng
  • [Grant] United States / Intramural NIH HHS / / ZIA HD008920-01
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Other-IDs] NLM/ NIHMS460457; NLM/ PMC3652406
  •  go-up   go-down


2. Arita S, Kikkawa F, Kajiyama H, Shibata K, Kawai M, Mizuno K, Nagasaka T, Ino K, Nomura S: Prognostic importance of vascular endothelial growth factor and its receptors in the uterine sarcoma. Int J Gynecol Cancer; 2005 Mar-Apr;15(2):329-36
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Prognostic importance of vascular endothelial growth factor and its receptors in the uterine sarcoma.
  • Vascular endothelial growth factor (VEGF) and its receptors play an important role in tumor progression; however, there is no report regarding this factor in uterine sarcoma.
  • Thirty-nine patients with uterine sarcoma, 14 carcinosarcomas, 4 endometrial stromal sarcomas, and 21 leiomyosarcomas, were studied.
  • The staining intensity of VEGF, flt-1, and flk-1 was significantly higher in sarcoma than in normal uterine smooth muscle, but that of phospho-flt-1 (p-flt-1) was significantly lower in sarcoma than in normal uterine smooth muscle.
  • When sarcomas were divided into two groups according to staining intensity, a significant difference in survival curves was observed in only p-flt-1 of leiomyosarcoma (P= 0.008), and in all sarcomas, a lower survival curve was also observed in the high staining intensity group than in the low staining intensity group, although there was no significant difference (P= 0.102).
  • In conclusion, VEGF and its receptors are suggested to be involved in progression of uterine sarcoma, but only the p-flt-1 level significantly affected the survival of leiomyosarcoma patients.
  • [MeSH-major] Biomarkers, Tumor / analysis. Carcinosarcoma / pathology. Leiomyosarcoma / pathology. Sarcoma / pathology. Sarcoma, Endometrial Stromal / pathology. Uterine Neoplasms / pathology. Vascular Endothelial Growth Factor A / analysis. Vascular Endothelial Growth Factor Receptor-1 / analysis. Vascular Endothelial Growth Factor Receptor-2 / analysis
  • [MeSH-minor] Adult. Aged. Disease Progression. Female. Humans. Immunohistochemistry. Middle Aged. Muscle, Smooth. Neoplasm Staging. Prognosis. Retrospective Studies. Survival Analysis

  • Genetic Alliance. consumer health - Uterine sarcoma.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15823121.001).
  • [ISSN] 1048-891X
  • [Journal-full-title] International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
  • [ISO-abbreviation] Int. J. Gynecol. Cancer
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Vascular Endothelial Growth Factor A; EC 2.7.10.1 / Vascular Endothelial Growth Factor Receptor-1; EC 2.7.10.1 / Vascular Endothelial Growth Factor Receptor-2
  •  go-up   go-down


3. Matsumura N, Mandai M, Miyanishi M, Fukuhara K, Baba T, Higuchi T, Kariya M, Takakura K, Fujii S: Oncogenic property of acrogranin in human uterine leiomyosarcoma: direct evidence of genetic contribution in in vivo tumorigenesis. Clin Cancer Res; 2006 Mar 1;12(5):1402-11
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Oncogenic property of acrogranin in human uterine leiomyosarcoma: direct evidence of genetic contribution in in vivo tumorigenesis.
  • To identify potential oncogenes that contribute to the development of uterine leiomyosarcoma, we conducted a cDNA microarray analysis between normal uterine smooth muscle and uterine leiomyosarcoma.
  • We found that acrogranin (also named PCDGF or progranulin) is overexpressed in uterine leiomyosarcoma.
  • With immunohistochemical staining of 12 leiomyosarcoma cases, we verified acrogranin expression in tumor cells.
  • Thus, acrogranin is overexpressed in uterine leiomyosarcoma cells, particularly in high-grade cases, and forced expression of acrogranin in immortalized uterine smooth muscle cells contributes to malignant transformation, which suggest that acrogranin plays an important role in the pathogenesis of uterine leiomyosarcoma.
  • [MeSH-major] Intercellular Signaling Peptides and Proteins / genetics. Leiomyosarcoma / metabolism. Uterine Neoplasms / metabolism
  • [MeSH-minor] Adult. Aged. Animals. Cell Adhesion. Cell Transformation, Neoplastic. DNA-Binding Proteins / genetics. Endometrium / metabolism. Endometrium / pathology. Female. Gene Expression Profiling. Humans. Mice. Mice, Inbred BALB C. Mice, Nude. Middle Aged. Myocytes, Smooth Muscle / metabolism. Myocytes, Smooth Muscle / pathology. Myometrium / cytology. Myometrium / metabolism. Myometrium / pathology. Oligonucleotide Array Sequence Analysis. RNA, Messenger / metabolism. Simian virus 40 / genetics. Telomerase / genetics. Transfection

  • Genetic Alliance. consumer health - Leiomyosarcoma.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16533762.001).
  • [ISSN] 1078-0432
  • [Journal-full-title] Clinical cancer research : an official journal of the American Association for Cancer Research
  • [ISO-abbreviation] Clin. Cancer Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA-Binding Proteins; 0 / GRN protein, human; 0 / Grn protein, mouse; 0 / Intercellular Signaling Peptides and Proteins; 0 / RNA, Messenger; EC 2.7.7.49 / Telomerase
  •  go-up   go-down


Advertisement
4. Rijcken E, Kersting CM, Senninger N, Bruewer M: Esophageal resection for giant leiomyoma: report of two cases and a review of the literature. Langenbecks Arch Surg; 2009 Jul;394(4):623-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Only histological and immunohistochemical examination could rule out malignant low grade leiomyosarcoma.
  • [MeSH-minor] Adult. Aged. Endoscopy, Digestive System. Humans. Immunohistochemistry. Leiomyosarcoma / diagnosis. Leiomyosarcoma / pathology. Male. Tomography, X-Ray Computed

  • MedlinePlus Health Information. consumer health - Esophageal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Clin Gastroenterol. 1987 Oct;9(5):613-5 [3500205.001]
  • [Cites] J Am Coll Surg. 2001 Oct;193(4):453 [11584975.001]
  • [Cites] Thorax. 1982 Jun;37(6):478-9 [7135285.001]
  • [Cites] World J Gastroenterol. 2005 Jul 21;11(27):4258-60 [16015702.001]
  • [Cites] Dis Esophagus. 2006;19(6):504-8 [17069596.001]
  • [Cites] World J Surg. 2000 Apr;24(4):401-11 [10706912.001]
  • [Cites] Am J Gastroenterol. 1983 Nov;78(11):708-11 [6637958.001]
  • [Cites] Scand Cardiovasc J. 1997;31(6):361-4 [9455786.001]
  • [Cites] Ann Thorac Cardiovasc Surg. 1998 Dec;4(6):351-3 [9914465.001]
  • [Cites] Jpn J Surg. 1988 Jul;18(4):460-4 [3172589.001]
  • [Cites] Ann Thorac Surg. 2005 Apr;79(4):1122-5 [15797036.001]
  • [Cites] Am J Gastroenterol. 1995 Mar;90(3):417-22 [7872281.001]
  • [Cites] Am J Gastroenterol. 1992 Nov;87(11):1669-71 [1442698.001]
  • [Cites] Dig Surg. 2000;17 (5):528-31 [11124564.001]
  • [Cites] J Exp Clin Cancer Res. 2005 Sep;24(3):487-91 [16270537.001]
  • [Cites] J Surg Oncol. 1986 Nov;33(3):166-9 [3773534.001]
  • [Cites] Surg Endosc. 1997 Mar;11(3):280-2 [9079610.001]
  • [Cites] Eur J Cardiothorac Surg. 2002 Dec;22(6):1008-10 [12467830.001]
  • [Cites] Dis Esophagus. 2008;21(1):90-3 [18197946.001]
  • [Cites] Scand J Thorac Cardiovasc Surg. 1984;18(2):145-50 [6087446.001]
  • [Cites] J Am Coll Surg. 2004 Jan;198(1):136-46 [14698321.001]
  • (PMID = 18594855.001).
  • [ISSN] 1435-2451
  • [Journal-full-title] Langenbeck's archives of surgery
  • [ISO-abbreviation] Langenbecks Arch Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


5. Gong YL, Li T, Guo H, Sun Y, Chi YK, Ling Y, Shen Q, Liu HJ, Hou L, Zhang B: [Expression of TEIF protein in soft tissue tumors and its significance]. Zhonghua Bing Li Xue Za Zhi; 2006 Nov;35(11):651-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The positive staining was predominantly in synovial sarcoma 94% (16/17), primitive neuroectodermal tumor (PNET) 91% (21/23), both of which were significantly higher than 43% (6/14) of dermatofibrosarcoma protuberans, 38% (6/16) of myxofibrosarcoma, 36% (8/22) of malignant peripheral nerve sheath tumor, 32% (6/19) of liposarcoma, (P < 0.05, respectively), but not higher than 75% (15/20) of malignant fibrous histiocytoma, 70% (7/10) of rhabdomyosarcoma or 64% (9/14) of leiomyosarcoma.
  • Meanwhile, strong positive staining of TEIF (>or= 2+) was frequently observed in PNET (83%, 19/23) and synovial sarcoma (76%, 13/17).
  • With respect to FNCLCC grading, 19 cases of grade I sarcoma TEIF was 32% (6/19) and strong positive was 11% (2/19), 44 cases of grade II sarcoma was 48% (21/44) and 32% (14/44), and 70 of grade III was 84% (59/70) and 70% (49/70).
  • The rate of either positive or strong positive in grade III sarcoma was significantly different from that of either grade I or II (P < 0.05), but no difference between the latter two groups (P > 0.05).
  • [MeSH-major] Sarcoma / metabolism. Soft Tissue Neoplasms / metabolism. Transcription Factors / biosynthesis
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Blotting, Western. Cell Line, Tumor. Child. Child, Preschool. Female. HeLa Cells. Histiocytoma, Malignant Fibrous / metabolism. Histiocytoma, Malignant Fibrous / pathology. Humans. Immunohistochemistry. Infant. Leiomyoma / metabolism. Leiomyoma / pathology. Male. Middle Aged. Neuroectodermal Tumors, Primitive / metabolism. Neuroectodermal Tumors, Primitive / pathology. Rhabdomyosarcoma / metabolism. Rhabdomyosarcoma / pathology. Sarcoma, Synovial / metabolism. Sarcoma, Synovial / pathology. Tissue Array Analysis. Young Adult

  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17374207.001).
  • [ISSN] 0529-5807
  • [Journal-full-title] Zhonghua bing li xue za zhi = Chinese journal of pathology
  • [ISO-abbreviation] Zhonghua Bing Li Xue Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Transcription Factors; EC 2.7.1.- / SCYL1 protein, human
  •  go-up   go-down


6. Sato M, Cismowski MJ, Toyota E, Smrcka AV, Lucchesi PA, Chilian WM, Lanier SM: Identification of a receptor-independent activator of G protein signaling (AGS8) in ischemic heart and its interaction with Gbetagamma. Proc Natl Acad Sci U S A; 2006 Jan 17;103(3):797-802
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • As part of a broader effort to identify postreceptor signal regulators involved in specific diseases or organ adaptation, we used an expression cloning system in Saccharomyces cerevisiae to screen cDNA libraries from rat ischemic myocardium, human heart, and a prostate leiomyosarcoma for entities that activated G protein signaling in the absence of a G protein coupled receptor.
  • Hypoxia induced AGS8 mRNA in isolated adult ventricular cardiomyocytes but not in rat aortic smooth muscle cells, endothelial cells, or cardiac fibroblasts, suggesting a myocyte-specific adaptation mechanism involving remodeling of G protein signaling pathways.

  • COS Scholar Universe. author profiles.
  • Faculty of 1000. commentaries/discussion - See the articles recommended by F1000Prime's Faculty of more than 8,000 leading experts in Biology and Medicine. (subscription/membership/fee required).
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Biol Chem. 1999 Nov 19;274(47):33202-5 [10559191.001]
  • [Cites] Circ Res. 2004 Apr 30;94(8):1133-41 [15031261.001]
  • [Cites] Annu Rev Physiol. 2000;62:79-109 [10845085.001]
  • [Cites] J Biol Chem. 2000 Aug 4;275(31):23421-4 [10840027.001]
  • [Cites] Circulation. 2000 Dec 19;102(25):3098-103 [11120701.001]
  • [Cites] EMBO J. 2001 Feb 15;20(4):767-76 [11179221.001]
  • [Cites] J Biol Chem. 2001 Jan 12;276(2):1585-93 [11042168.001]
  • [Cites] J Biol Chem. 2004 Jun 25;279(26):27567-74 [15096500.001]
  • [Cites] Circulation. 2004 Jun 22;109(24):3042-9 [15184284.001]
  • [Cites] Neuron. 2004 Sep 2;43(5):715-28 [15339652.001]
  • [Cites] J Biol Chem. 1996 Nov 22;271(47):30052-60 [8939952.001]
  • [Cites] Structure. 1996 Nov 15;4(11):1277-90 [8939752.001]
  • [Cites] Science. 1998 May 22;280(5367):1271-4 [9596582.001]
  • [Cites] Cell. 1999 Jul 9;98(1):59-68 [10412981.001]
  • [Cites] Nat Biotechnol. 1999 Sep;17(9):878-83 [10471929.001]
  • [Cites] J Biol Chem. 2005 Mar 18;280(11):10174-81 [15611108.001]
  • [Cites] EMBO J. 2005 Jun 1;24(11):1965-75 [15889144.001]
  • [Cites] Genes Dev. 2005 Jun 1;19(11):1341-53 [15937221.001]
  • [Cites] J Biol Chem. 2005 Jun 10;280(23):22012-20 [15749703.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Jun 14;102(24):8746-51 [15937104.001]
  • [Cites] Cell. 2005 Jul 15;122(1):119-31 [16009138.001]
  • [Cites] Trends Pharmacol Sci. 2005 Sep;26(9):470-6 [16084602.001]
  • [Cites] Circulation. 2005 Oct 4;112(14):2108-13 [16203926.001]
  • [Cites] Nat Cell Biol. 2005 Nov;7(11):1083-90 [16228010.001]
  • [Cites] Nat Cell Biol. 2005 Nov;7(11):1091-8 [16228012.001]
  • [Cites] Nat Cell Biol. 2005 Nov;7(11):1099-105 [16228011.001]
  • [Cites] Rev Physiol Biochem Pharmacol. 2005;155:57-80 [16041530.001]
  • [Cites] J Biol Chem. 2001 Apr 6;276(14):11246-51 [11145956.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Jul 31;98(16):9336-41 [11481491.001]
  • [Cites] Methods Enzymol. 2002;344:153-68 [11771380.001]
  • [Cites] J Biol Chem. 2002 Mar 1;277(9):6767-70 [11756403.001]
  • [Cites] J Biol Chem. 2002 Oct 18;277(42):39728-38 [12145288.001]
  • [Cites] J Biol Chem. 2002 Dec 20;277(51):49888-95 [12359736.001]
  • [Cites] FEBS Lett. 2003 Feb 11;536(1-3):35-40 [12586334.001]
  • [Cites] Curr Biol. 2003 Jun 17;13(12):1029-37 [12814548.001]
  • [Cites] Science. 2003 Jun 20;300(5627):1957-61 [12750478.001]
  • [Cites] Am J Physiol Heart Circ Physiol. 2003 Aug;285(2):H784-92 [12663259.001]
  • [Cites] Neuron. 2004 Apr 22;42(2):269-81 [15091342.001]
  • [Cites] J Biol Chem. 2000 Feb 18;275(7):4693-8 [10671499.001]
  • (PMID = 16407149.001).
  • [ISSN] 0027-8424
  • [Journal-full-title] Proceedings of the National Academy of Sciences of the United States of America
  • [ISO-abbreviation] Proc. Natl. Acad. Sci. U.S.A.
  • [Language] ENG
  • [Databank-accession-numbers] GENBANK/ DQ256268
  • [Grant] United States / NCRR NIH HHS / RR / P20 RR018766; United States / NINDS NIH HHS / NS / R01 NS024821; United States / NIMH NIH HHS / MH / MH55391; United States / NINDS NIH HHS / NS / NS24821
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Fndc1 protein, rat; 0 / G-protein Beta gamma; 0 / GTP-Binding Protein beta Subunits; 0 / GTP-Binding Protein gamma Subunits; 0 / Intracellular Signaling Peptides and Proteins; EC 3.6.1.- / GTP-Binding Proteins; EC 3.6.5.2 / ras Proteins
  • [Other-IDs] NLM/ PMC1334649
  •  go-up   go-down


7. Barker KT, Spendlove HE, Banu NS, Bridge JA, Fisher C, Shipley J, Garrett M, Manyonda I, Houlston RS: No evidence for epigenetic inactivation of fumarate hydratase in leiomyomas and leiomyosarcomas. Cancer Lett; 2006 Apr 8;235(1):136-40
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Epigenesis, Genetic. Fumarate Hydratase / genetics. Leiomyoma / genetics. Leiomyosarcoma / genetics. Uterine Neoplasms / genetics
  • [MeSH-minor] Adult. Animals. Female. Humans. Immunoglobulin G / immunology. Middle Aged. Mutation / genetics. Myometrium / enzymology. Myometrium / pathology. Rabbits

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Fibroids.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15949892.001).
  • [ISSN] 0304-3835
  • [Journal-full-title] Cancer letters
  • [ISO-abbreviation] Cancer Lett.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / P30 CA 36727; United Kingdom / Wellcome Trust / /
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] Ireland
  • [Chemical-registry-number] 0 / Immunoglobulin G; EC 4.2.1.2 / Fumarate Hydratase
  •  go-up   go-down


8. Bilici A, Uygun K, Altun E, Karci E, Gurbuz Y, Semih Dogan A: Primary peritoneal spindle cell sarcoma presented with massive ascites: a case report. J BUON; 2009 Oct-Dec;14(4):721-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary peritoneal spindle cell sarcoma presented with massive ascites: a case report.
  • Primary peritoneal sarcomas have been reported as leiomyosarcoma, liposarcoma and carcinosarcoma.
  • However, primary peritoneal spindle cell sarcoma has never been reported in the literature.
  • Herein, we report on a 38-year-old woman with massive ascites diagnosed as primary peritoneal spindle cell sarcoma.
  • [MeSH-major] Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Ascites / etiology. Peritoneal Neoplasms / complications. Sarcoma / complications. Soft Tissue Neoplasms / complications
  • [MeSH-minor] Adult. Doxorubicin / administration & dosage. Female. Humans. Ifosfamide / administration & dosage. Prognosis. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • Hazardous Substances Data Bank. DOXORUBICIN .
  • Hazardous Substances Data Bank. IFOSFAMIDE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20148470.001).
  • [ISSN] 1107-0625
  • [Journal-full-title] Journal of B.U.ON. : official journal of the Balkan Union of Oncology
  • [ISO-abbreviation] J BUON
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Greece
  • [Chemical-registry-number] 80168379AG / Doxorubicin; UM20QQM95Y / Ifosfamide
  •  go-up   go-down


9. Ali MO, Rashid MM, Saifullah M, Ahmed T: Upper abdominal mass with diagnostic dilemma. Mymensingh Med J; 2009 Jan;18(1):99-103
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Histopathology report comments about two differential diagnosis-leiomyosarcoma and gastrointestinal stromal tumour.

  • MedlinePlus Health Information. consumer health - Cancer Chemotherapy.
  • Hazardous Substances Data Bank. IMATINIB MESYLATE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19182760.001).
  • [ISSN] 1022-4742
  • [Journal-full-title] Mymensingh medical journal : MMJ
  • [ISO-abbreviation] Mymensingh Med J
  • [Language] ENG
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Bangladesh
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Benzamides; 0 / Piperazines; 0 / Pyrimidines; 8A1O1M485B / Imatinib Mesylate
  •  go-up   go-down


10. Ul-Hassan A, Sisley K, Hughes D, Hammond DW, Robinson MH, Reed MW: Common genetic changes in leiomyosarcoma and gastrointestinal stromal tumour: implication for ataxia telangiectasia mutated involvement. Int J Exp Pathol; 2009 Oct;90(5):549-57
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Common genetic changes in leiomyosarcoma and gastrointestinal stromal tumour: implication for ataxia telangiectasia mutated involvement.
  • Leiomyosarcoma is a malignant tumour of smooth muscle differentiation and falls into a group of sarcomas that show complex karyotypic changes with no consistent recurrent genetic abnormality.
  • We found leiomyosarcomas and GISTs share common regions of chromosomal 13q and 11q imbalance, in addition to more specific 1p and 8p losses in leiomyosarcoma and 15q and 22q losses in GISTs.
  • More importantly, we have shown for the first time a deletion in the ataxia telangiectasia mutated (ATM) gene locus with decreased/absent expression of ATM protein, and amplification in the region 13q21-q32 in both tumour types, suggesting both regions may play a role in leiomyosarcoma and GIST biology.
  • [MeSH-major] Cell Cycle Proteins / genetics. DNA-Binding Proteins / genetics. Gastrointestinal Stromal Tumors / genetics. Leiomyosarcoma / genetics. Neoplasm Proteins / genetics. Protein-Serine-Threonine Kinases / genetics. Tumor Suppressor Proteins / genetics
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Ataxia Telangiectasia Mutated Proteins. Chromosome Deletion. Chromosomes, Human, Pair 11 / genetics. Chromosomes, Human, Pair 13 / genetics. Comparative Genomic Hybridization. Down-Regulation. Female. Gene Amplification. Humans. In Situ Hybridization, Fluorescence. Male. Middle Aged


11. Illuminati G, Calio' FG, D'Urso A, Giacobbi D, Papaspyropoulos V, Ceccanei G: Prosthetic replacement of the infrahepatic inferior vena cava for leiomyosarcoma. Arch Surg; 2006 Sep;141(9):919-24; discussion 924
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Prosthetic replacement of the infrahepatic inferior vena cava for leiomyosarcoma.
  • HYPOTHESIS: Resection of the infrahepatic inferior vena cava associated with prosthetic graft replacement for caval leiomyosarcoma is an acceptable procedure to obtain prolonged and good-quality survival.
  • PATIENTS: Eleven patients, with a mean age of 51 years, who have primary leiomyosarcoma of the infrahepatic inferior vena cava.
  • CONCLUSION: Radical resection followed by prosthetic graft reconstruction is a valuable method for treating primary leiomyosarcoma of the infrahepatic inferior vena cava.
  • [MeSH-major] Blood Vessel Prosthesis. Blood Vessel Prosthesis Implantation / methods. Leiomyosarcoma / surgery. Vascular Neoplasms / surgery. Vena Cava, Inferior / surgery
  • [MeSH-minor] Adult. Aged. Female. Graft Survival. Humans. Male. Middle Aged. Polytetrafluoroethylene. Postoperative Complications. Survival Analysis. Tomography, X-Ray Computed. Treatment Outcome. Vascular Patency

  • Genetic Alliance. consumer health - Leiomyosarcoma.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. TEFLON .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16983035.001).
  • [ISSN] 0004-0010
  • [Journal-full-title] Archives of surgery (Chicago, Ill. : 1960)
  • [ISO-abbreviation] Arch Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 9002-84-0 / Polytetrafluoroethylene
  •  go-up   go-down


12. Laffosse JM, Gomez-Brouchet A, Giordano G, Bonnevialle N, Puget J: Intraosseous leiomyoma: a report of two cases. Joint Bone Spine; 2007 Jul;74(4):389-92
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Intraosseous leiomyosarcoma is the main differential diagnosis.
  • [MeSH-minor] Adult. Ankle Joint. Biopsy, Needle. Bone Transplantation / methods. Female. Follow-Up Studies. Hip Joint. Humans. Immunohistochemistry. Magnetic Resonance Imaging. Male. Middle Aged. Orthopedic Procedures / methods. Rare Diseases. Risk Assessment. Tomography, X-Ray Computed. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17587627.001).
  • [ISSN] 1778-7254
  • [Journal-full-title] Joint, bone, spine : revue du rhumatisme
  • [ISO-abbreviation] Joint Bone Spine
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] France
  •  go-up   go-down


13. Cornfeld D, Israel G, Martel M, Weinreb J, Schwartz P, McCarthy S: MRI appearance of mesenchymal tumors of the uterus. Eur J Radiol; 2010 Apr;74(1):241-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Statistically, a uterine mass with unusual imaging features is more likely to represent a leiomyoma than other uncommon uterine mesenchymal neoplasms such as leiomyosarcoma or endometrial stromal tumors.
  • Four patients with uterine leiomyosarcoma, two with stromal tumors of uncertain malignant potential (STUMP), one with endometrial stromal sarcoma, and two with mixed endometrial stromal and smooth muscle tumors were included in the study.
  • [MeSH-major] Leiomyosarcoma / radiography. Rhabdomyosarcoma / radiography. Sarcoma, Endometrial Stromal / radiography. Uterine Neoplasms / radiography
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Endometrial Neoplasms / radiography. Female. Humans. Magnetic Resonance Imaging. Middle Aged. Retrospective Studies

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2010 Elsevier Ireland Ltd. All rights reserved.
  • (PMID = 19349135.001).
  • [ISSN] 1872-7727
  • [Journal-full-title] European journal of radiology
  • [ISO-abbreviation] Eur J Radiol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Ireland
  •  go-up   go-down


14. Tewari D, Saffari B, Cowan C, Wallick AC, Koontz MZ, Monk BJ: Activity of trabectedin (ET-743, Yondelis) in metastatic uterine leiomyosarcoma. Gynecol Oncol; 2006 Sep;102(3):421-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Activity of trabectedin (ET-743, Yondelis) in metastatic uterine leiomyosarcoma.
  • CASE: A case of advanced, recurrent and refractory uterine leiomyosarcoma is presented that responded to trabectedin (ET-743) 1.2 mg/m2 intravenously over 24 h every 3 weeks after failing four prior regimens.
  • CONCLUSION: Trabectedin (ET-743) has activity in uterine leiomyosarcoma and warrants further investigation.
  • [MeSH-major] Antineoplastic Agents, Alkylating / therapeutic use. Dioxoles / therapeutic use. Leiomyosarcoma / drug therapy. Tetrahydroisoquinolines / therapeutic use. Uterine Neoplasms / drug therapy
  • [MeSH-minor] Adult. Drug Administration Schedule. Drugs, Investigational / therapeutic use. Female. Humans. Lung Neoplasms / secondary. Neoplasm Recurrence, Local

  • Genetic Alliance. consumer health - Leiomyosarcoma.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16797679.001).
  • [ISSN] 0090-8258
  • [Journal-full-title] Gynecologic oncology
  • [ISO-abbreviation] Gynecol. Oncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents, Alkylating; 0 / Dioxoles; 0 / Drugs, Investigational; 0 / Tetrahydroisoquinolines; 114899-77-3 / trabectedin
  •  go-up   go-down


15. Patel J, Sheppard MN: Pathological study of primary cardiac and pericardial tumours in a specialist UK Centre: surgical and autopsy series. Cardiovasc Pathol; 2010 Nov-Dec;19(6):343-52
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Among cases with primary malignant tumours (n=27, 28.7%), unclassified sarcoma (n=11), leiomyosarcoma (n=5), and lymphoma (n=4) were the most common histologic types.
  • CONCLUSION: This study, primarily from an adult setting (n=78, 83%) demonstrates a large spectrum of cardiac tumours seen in recent cardiologic practice.
  • [MeSH-major] Fibroma / pathology. Heart Neoplasms / pathology. Lymphoma / pathology. Myxoma / pathology. Pericardium / pathology. Sarcoma / pathology
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Autopsy. Cardiac Surgical Procedures. Child. Female. Humans. Infant. Infant, Newborn. Leiomyosarcoma / pathology. London. Male. Middle Aged. Prognosis. Retrospective Studies. Young Adult

  • MedlinePlus Health Information. consumer health - Lymphoma.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 Elsevier Inc. All rights reserved.
  • (PMID = 19747857.001).
  • [ISSN] 1879-1336
  • [Journal-full-title] Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology
  • [ISO-abbreviation] Cardiovasc. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


16. Patton KT, Cheng L, Papavero V, Blum MG, Yeldandi AV, Adley BP, Luan C, Diaz LK, Hui P, Yang XJ: Benign metastasizing leiomyoma: clonality, telomere length and clinicopathologic analysis. Mod Pathol; 2006 Jan;19(1):130-40
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Speculations on its pathogenesis include a benign uterine leiomyoma colonizing the lung, a metastatic low-grade uterine leiomyosarcoma, and primary pulmonary leiomyomatosis.
  • [MeSH-minor] Adult. Clone Cells / chemistry. Clone Cells / metabolism. Clone Cells / pathology. Female. Humans. Immunohistochemistry. In Situ Hybridization, Fluorescence. Lung / pathology. Lung / radiography. Receptors, Androgen / genetics. Receptors, Estrogen / analysis. Receptors, Progesterone / analysis. Telomere / genetics. Tomography, X-Ray Computed. Trinucleotide Repeats / genetics. X Chromosome Inactivation / genetics

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Fibroids.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16357844.001).
  • [ISSN] 0893-3952
  • [Journal-full-title] Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
  • [ISO-abbreviation] Mod. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Receptors, Androgen; 0 / Receptors, Estrogen; 0 / Receptors, Progesterone
  •  go-up   go-down


17. Villar Luque LM, Sau Llanas P, Cantero Sánchez M, Maldonado Taillefer M, Gómez AM: [PET-FDG study in a patient with history of uterine leiomyosarcoma during menstruation and a false positive result]. Rev Esp Med Nucl; 2005 May-Jun;24(3):205-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [PET-FDG study in a patient with history of uterine leiomyosarcoma during menstruation and a false positive result].
  • [MeSH-major] Fluorodeoxyglucose F18. Leiomyosarcoma / radionuclide imaging. Menstruation. Positron-Emission Tomography. Radiopharmaceuticals. Uterine Neoplasms / radionuclide imaging. Uterus / radionuclide imaging
  • [MeSH-minor] Adult. False Positive Reactions. Female. Humans. Hysterectomy

  • Genetic Alliance. consumer health - Leiomyosarcoma.
  • MedlinePlus Health Information. consumer health - Menstruation.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15847790.001).
  • [ISSN] 0212-6982
  • [Journal-full-title] Revista española de medicina nuclear
  • [ISO-abbreviation] Rev Esp Med Nucl
  • [Language] spa
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Spain
  • [Chemical-registry-number] 0 / Radiopharmaceuticals; 0Z5B2CJX4D / Fluorodeoxyglucose F18
  •  go-up   go-down


18. Anderson S, Aghajanian C: Temozolomide in uterine leiomyosarcomas. Gynecol Oncol; 2005 Jul;98(1):99-103
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We review the Memorial Sloan-Kettering Cancer Center (MSKCC) experience in women with metastatic or unresectable leiomyosarcoma treated with continuous daily dose (CDD) or bolus-dose (BD) temozolomide.
  • We include a literature review of temozolomide activity in leiomyosarcoma patients.
  • METHODS: After obtaining Institutional Review Board approval, we identified women with recurrent leiomyosarcoma treated with temozolomide at MSKCC from 9/2001 to 9/2004.
  • CONCLUSIONS: Temozolomide has promising therapeutic benefit and is well tolerated in patients with metastatic unresectable leiomyosarcoma.
  • Further investigation of temozolomide in leiomyosarcoma patients is warranted.
  • [MeSH-major] Antineoplastic Agents, Alkylating / administration & dosage. Dacarbazine / administration & dosage. Dacarbazine / analogs & derivatives. Leiomyosarcoma / drug therapy. Uterine Neoplasms / drug therapy
  • [MeSH-minor] Adult. Aged. Drug Administration Schedule. Female. Humans. Middle Aged. Neoplasm Staging

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • Hazardous Substances Data Bank. DACARBAZINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15916799.001).
  • [ISSN] 0090-8258
  • [Journal-full-title] Gynecologic oncology
  • [ISO-abbreviation] Gynecol. Oncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents, Alkylating; 7GR28W0FJI / Dacarbazine; 85622-93-1 / temozolomide
  • [Number-of-references] 16
  •  go-up   go-down


19. Srour J, Pasumarthy L: Leiomyosarcoma of the inferior vena cava-a rare cause of abdominal pain. Am J Med Sci; 2009 May;337(5):369
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Leiomyosarcoma of the inferior vena cava-a rare cause of abdominal pain.
  • [MeSH-major] Abdominal Pain / etiology. Leiomyosarcoma / diagnosis. Leiomyosarcoma / pathology. Vascular Neoplasms / diagnosis. Vascular Neoplasms / pathology. Vena Cava, Inferior / abnormalities
  • [MeSH-minor] Adult. Female. Hepatitis B / complications. Humans. Immunohistochemistry

  • Genetic Alliance. consumer health - Leiomyosarcoma.
  • MedlinePlus Health Information. consumer health - Abdominal Pain.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19440060.001).
  • [ISSN] 0002-9629
  • [Journal-full-title] The American journal of the medical sciences
  • [ISO-abbreviation] Am. J. Med. Sci.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


20. Zhang ZL, Zhang Y, Zhou JH: [Expression of bcl-2 and bax protein in uterine leiomyosarcomas and leiomyomas]. Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Apr;30(2):183-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: Bcl-2 expression was higher in uterine leiomyomas than that in normal myometrium and in uterine leiomyosarcoma (P < 0.01 ); bcl-2 expression in uterine leiomyosarcoma was higher than that in normal myometrium (P < 0.05).
  • Bax expression in normal myometrium was higher than that in leiomyomas and in uterine leiomyosarcoma (P < 0.01).
  • There was no obvious difference in bax expression between leiomyomas and leiomyosarcoma (P > 0.05).
  • The bcl-2 positive leiomyosarcoma has a favorable clinical outcome than that of bcl-2 negative.
  • Bcl-2 and bax may be involved in the early stage of the tumor genesis of uterine leiomyosarcoma.
  • Bcl-2 might correlate with the prognosis of the uterine leiomyosarcoma.
  • [MeSH-major] Leiomyoma / metabolism. Leiomyosarcoma / metabolism. Proto-Oncogene Proteins c-bcl-2 / biosynthesis. Uterine Neoplasms / metabolism. bcl-2-Associated X Protein / biosynthesis
  • [MeSH-minor] Adolescent. Adult. Aged. Child. Female. Follow-Up Studies. Humans. Middle Aged. Prognosis

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Fibroids.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15898430.001).
  • [ISSN] 1672-7347
  • [Journal-full-title] Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences
  • [ISO-abbreviation] Zhong Nan Da Xue Xue Bao Yi Xue Ban
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Proto-Oncogene Proteins c-bcl-2; 0 / bcl-2-Associated X Protein
  •  go-up   go-down


21. Juang CM, Yen MS, Horng HC, Twu NF, Yu HC, Hsu WL: Potential role of preoperative serum CA125 for the differential diagnosis between uterine leiomyoma and uterine leiomyosarcoma. Eur J Gynaecol Oncol; 2006;27(4):370-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Potential role of preoperative serum CA125 for the differential diagnosis between uterine leiomyoma and uterine leiomyosarcoma.
  • PURPOSE: Most comparisons between uterine leiomyoma and uterine leiomyosarcoma have been based on postoperative pathological or molecular analyses.
  • Very few reports have investigated preoperative differentiation between uterine leiomyoma and uterine leiomyosarcoma.
  • METHODS: Between January 1990 and December 2003, 42 consecutive patients with uterine leiomyosarcoma treated at index hospitals were analyzed.
  • The diagnostic performance of preoperative serum CA125 for the differential diagnosis between uterine leiomyoma and uterine leiomyosarcoma using receiver operating characteristic (ROC) curves was evaluated.
  • RESULTS: Values of preoperative serum CA125 were significantly higher in the uterine leiomyosarcoma group than those in the uterine leiomyoma group.
  • There was significant overlapping of preoperative serum CA125 between the uterine leiomyoma group and early-stage uterine leiomyosarcoma.
  • For both the premenopausal and postmenopausal group, there was a significant difference in the distribution of preoperative serum CA125 in early-stage and advanced-stage uterine leiomyosarcoma.
  • CONCLUSION: These findings demonstrated that preoperative serum CA125 had a potential role in the differential diagnosis between early-stage and advanced-stage uterine leiomyosarcoma.
  • [MeSH-major] CA-125 Antigen / blood. Diagnosis, Differential. Leiomyoma / diagnosis. Leiomyosarcoma / diagnosis. Uterine Neoplasms / diagnosis
  • [MeSH-minor] Adult. Female. Humans. Middle Aged. Preoperative Care


22. Rioja Zuazu J, Rosell Costa D, Rincón Mayans A, Saiz Sansi A, Panizo Santos A, Berián Polo JM: [Bladder leiomiosarcoma. A new case and a review of the literatura]. Actas Urol Esp; 2009 Jul-Aug;33(7):816-21
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Leiomyosarcoma. Urinary Bladder Neoplasms
  • [MeSH-minor] Adult. Female. Humans

  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19757669.001).
  • [ISSN] 0210-4806
  • [Journal-full-title] Actas urologicas españolas
  • [ISO-abbreviation] Actas Urol Esp
  • [Language] spa
  • [Publication-type] Case Reports; English Abstract; Journal Article; Review
  • [Publication-country] Spain
  • [Number-of-references] 24
  •  go-up   go-down


23. Watanabe K, Suzuki T: Uterine leiomyoma versus leiomyosarcoma: a new attempt at differential diagnosis based on their cellular characteristics. Histopathology; 2006 Apr;48(5):563-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Uterine leiomyoma versus leiomyosarcoma: a new attempt at differential diagnosis based on their cellular characteristics.
  • AIM: To differentiate uterine leiomyoma (LM) with 'pseudosarcomatous' features from leiomyosarcoma (LMS).
  • The tumours of the adverse outcome group were composed of rather uniform long spindle cells similar to those of leiomyosarcoma arising from the soft tissue.
  • [MeSH-major] Leiomyoma / pathology. Leiomyosarcoma / pathology. Uterine Neoplasms / pathology
  • [MeSH-minor] Actins / analysis. Adult. Calmodulin-Binding Proteins / analysis. Desmin / analysis. Diagnosis, Differential. Female. Humans. Immunohistochemistry. Middle Aged. Muscle, Smooth / chemistry. Prognosis. Receptors, Estrogen / analysis. Receptors, Progesterone / analysis


24. Lee FY, Wen MC, Wang J: Epithelioid leiomyosarcoma of the uterus containing sex cord-like elements. Int J Gynecol Pathol; 2010 Jan;29(1):67-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Epithelioid leiomyosarcoma of the uterus containing sex cord-like elements.
  • [MeSH-major] Leiomyosarcoma / pathology. Uterine Neoplasms / pathology
  • [MeSH-minor] Adult. Female. Humans. Hysterectomy

  • Genetic Alliance. consumer health - Leiomyosarcoma.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19952934.001).
  • [ISSN] 1538-7151
  • [Journal-full-title] International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists
  • [ISO-abbreviation] Int. J. Gynecol. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Letter
  • [Publication-country] United States
  •  go-up   go-down


25. Strina C, Zannoni M, Parolin V, Cetto GL, Zuliani S: Bone metastases from primary cardiac sarcoma: case report. Tumori; 2009 Mar-Apr;95(2):251-3
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Bone metastases from primary cardiac sarcoma: case report.
  • Tumor spread from primary cardiac sarcoma to the bone is very rare and has a poor prognosis.
  • We present a 32-year-old female patient with bone metastases from primary cardiac sarcoma.
  • [MeSH-major] Bone Neoplasms / secondary. Heart Neoplasms / pathology. Leiomyosarcoma / secondary
  • [MeSH-minor] Adult. Biopsy. Female. Femur / pathology. Humans. Magnetic Resonance Imaging

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19579876.001).
  • [ISSN] 0300-8916
  • [Journal-full-title] Tumori
  • [ISO-abbreviation] Tumori
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


26. Shukla R, Pooja B, Radhika S, Nijhawan R, Rajwanshi A: Fine-needle aspiration cytology of extramammary neoplasms metastatic to the breast. Diagn Cytopathol; 2005 Apr;32(4):193-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The adult cases included two cases each of melanoma, small-cell carcinoma, and myeloma; one case of choriocarcinoma; and three cases of soft-tissue sarcomas.
  • These included two cases of malignant fibrous histiocytoma (MFH) and one case of leiomyosarcoma.
  • [MeSH-minor] Adolescent. Adult. Biopsy, Fine-Needle. Child. Female. Humans. Male. Middle Aged. Neoplasm Metastasis / pathology. Predictive Value of Tests

  • MedlinePlus Health Information. consumer health - Male Breast Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2005 Wiley-Liss, Inc.
  • (PMID = 15754368.001).
  • [ISSN] 8755-1039
  • [Journal-full-title] Diagnostic cytopathology
  • [ISO-abbreviation] Diagn. Cytopathol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


27. Gojnic M, Likic I, Pervulov M, Petkovic S, Fazlagic A, Vasiljevic B: The significance of Doppler flow in early detection of uterine sarcoma in older primigravida pregnancies. Eur J Gynaecol Oncol; 2005;26(3):291-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The significance of Doppler flow in early detection of uterine sarcoma in older primigravida pregnancies.
  • In conditions where the resistance index showed the possibility of uterine sarcoma, the pregnancy was ended by surgery; not only was myomectomy performed but also complete uterine hysterectomy with the previous consent of the patient.
  • Considering the obstetrical findings, other patients were delivered vaginally or operatively, but after puerperium they were subjected to control examinations and myomectomy because Doppler flow findings did not show any indications of sarcoma.
  • By histopathological analysis, we received benign results in 31 cases, while in four cases where we decided on hysterectomy and surgical delivery, we received malignant results, i.e. leiomyosarcoma.
  • [MeSH-major] Leiomyoma / ultrasonography. Leiomyosarcoma / ultrasonography. Pregnancy Complications, Neoplastic / ultrasonography. Uterine Neoplasms / ultrasonography
  • [MeSH-minor] Adult. Age Factors. Female. Gravidity. Gynecologic Surgical Procedures. Humans. Pregnancy. Ultrasonics


28. Suppiah R, Wood L, Elson P, Budd GT: Phase I/II study of docetaxel, ifosfamide, and doxorubicin in advanced, recurrent, or metastatic soft tissue sarcoma (STS). Invest New Drugs; 2006 Nov;24(6):509-14
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Phase I/II study of docetaxel, ifosfamide, and doxorubicin in advanced, recurrent, or metastatic soft tissue sarcoma (STS).
  • HISTOLOGY: leiomyosarcoma 10, spindle cell sarcoma 3, synovial sarcoma 2, angiosarcoma 1, fibrous histiocytoma 1, epitheliod hemangio-endothelioma 1, and 3 not specified.
  • [MeSH-major] Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Sarcoma / drug therapy
  • [MeSH-minor] Adult. Aged. Antineoplastic Agents, Alkylating / administration & dosage. Doxorubicin / administration & dosage. Female. Humans. Ifosfamide / administration & dosage. Male. Maximum Tolerated Dose. Middle Aged. Survival Analysis. Taxoids / administration & dosage

  • Genetic Alliance. consumer health - Soft tissue sarcoma.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • Hazardous Substances Data Bank. DOCETAXEL .
  • Hazardous Substances Data Bank. DOXORUBICIN .
  • Hazardous Substances Data Bank. IFOSFAMIDE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Crit Rev Oncol Hematol. 1995 Oct;20(3):193-201 [8748009.001]
  • [Cites] Cancer. 1981 May 15;47(10):2422-9 [7272896.001]
  • [Cites] J Clin Oncol. 1995 Jul;13(7):1600-8 [7541449.001]
  • [Cites] CA Cancer J Clin. 2004 Jan-Feb;54(1):8-29 [14974761.001]
  • [Cites] Clin Ter. 1998 Mar-Apr;149(2):121-5 [9780476.001]
  • [Cites] Cancer. 1982 Dec 15;50(12):2757-62 [7139566.001]
  • [Cites] J Clin Oncol. 1999 Jan;17(1):150-7 [10458228.001]
  • [Cites] Ann Oncol. 1999 Sep;10(9):1087-94 [10572607.001]
  • [Cites] J Clin Oncol. 1993 Jul;11(7):1276-85 [8315425.001]
  • [Cites] Ann Oncol. 2001 Sep;12(9):1281-8 [11697841.001]
  • [Cites] J Clin Oncol. 1987 Jun;5(6):840-50 [3585441.001]
  • [Cites] Eur J Cancer. 2002 Dec;38(18):2397-406 [12460784.001]
  • [Cites] Cancer. 1984 May 1;53(9):1825-32 [6367947.001]
  • [Cites] Am J Clin Oncol. 1996 Dec;19(6):574-6 [8931674.001]
  • [Cites] Cancer. 1994 May 15;73(10):2506-11 [8174046.001]
  • [Cites] J Clin Oncol. 2000 May;18(10):2081-6 [10811673.001]
  • [Cites] Ann Oncol. 1994 Jul;5(6):539-42 [7918126.001]
  • [Cites] J Clin Oncol. 1993 Jan;11(1):15-21 [8418226.001]
  • [Cites] J Clin Oncol. 2004 May 1;22(9):1706-12 [15117993.001]
  • [Cites] J Clin Oncol. 1993 Jul;11(7):1269-75 [8315424.001]
  • [Cites] J Clin Oncol. 2002 Jun 15;20(12):2824-31 [12065559.001]
  • [Cites] J Clin Oncol. 1997 Jun;15(6):2378-84 [9196153.001]
  • (PMID = 16791410.001).
  • [ISSN] 0167-6997
  • [Journal-full-title] Investigational new drugs
  • [ISO-abbreviation] Invest New Drugs
  • [Language] eng
  • [Publication-type] Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents, Alkylating; 0 / Taxoids; 15H5577CQD / docetaxel; 80168379AG / Doxorubicin; UM20QQM95Y / Ifosfamide
  •  go-up   go-down


29. Ma SK, Zhang HT, Wu LY, Liu LY, Li B: [Border-line smooth-muscle tumor of the uterus: analysis of 131 patients]. Zhonghua Zhong Liu Za Zhi; 2005 Nov;27(11):698-700
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVE: To investigate whether the border-line uterine smooth-muscle tumor is different from leiomyoma or leiomyosarcoma in history and clinical manifestations.
  • [MeSH-major] Leiomyosarcoma / pathology. Smooth Muscle Tumor / pathology. Uterine Neoplasms / pathology
  • [MeSH-minor] Adult. Diagnosis, Differential. Female. Follow-Up Studies. Humans. Leiomyoma / pathology. Leiomyoma / surgery. Male. Middle Aged. Neoplasm Recurrence, Local. Retrospective Studies. Survival Rate

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16438896.001).
  • [ISSN] 0253-3766
  • [Journal-full-title] Zhonghua zhong liu za zhi [Chinese journal of oncology]
  • [ISO-abbreviation] Zhonghua Zhong Liu Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


30. Akahira J, Tokunaga H, Toyoshima M, Takano T, Nagase S, Yoshinaga K, Tase T, Wada Y, Ito K, Niikura H, Yamada H, Sato A, Sasano H, Yaegashi N: Prognoses and prognostic factors of carcinosarcoma, endometrial stromal sarcoma and uterine leiomyosarcoma: a comparison with uterine endometrial adenocarcinoma. Oncology; 2006;71(5-6):333-40
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Prognoses and prognostic factors of carcinosarcoma, endometrial stromal sarcoma and uterine leiomyosarcoma: a comparison with uterine endometrial adenocarcinoma.
  • [MeSH-major] Adenocarcinoma / diagnosis. Carcinosarcoma / diagnosis. Endometrial Neoplasms / diagnosis. Leiomyosarcoma / diagnosis. Sarcoma, Endometrial Stromal / diagnosis. Uterine Neoplasms / diagnosis
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Female. Humans. Japan. Middle Aged. Multivariate Analysis. Prognosis. Survival Rate


31. Nga ME, Lim GL, Barbro N, Chan NH: Successful retrieval of fine-needle aspiration biopsy material from previously stained smears for immunocytochemistry: a novel technique applied to three soft tissue tumors. Mod Pathol; 2005 May;18(5):728-32
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We subvent this problem by employing a new 'cytoscrape' technique to create cell blocks from previously Papanicolaou-stained smear material in two cases of mesenchymal tumors where smear diagnoses were limited to 'sarcoma, not otherwise specified'.
  • [MeSH-major] Biopsy, Fine-Needle / standards. Sarcoma / pathology
  • [MeSH-minor] Actins / analysis. Adult. Antigens, CD31 / analysis. Antigens, CD34 / analysis. Cytodiagnosis / methods. Cytodiagnosis / standards. Factor VIII / analysis. Female. Fibrosarcoma / metabolism. Fibrosarcoma / pathology. Hemangiosarcoma / metabolism. Hemangiosarcoma / pathology. Humans. Immunohistochemistry. Leiomyosarcoma / metabolism. Leiomyosarcoma / pathology. Male. Middle Aged. Muscle, Smooth / chemistry. Proto-Oncogene Proteins c-kit / analysis. Specimen Handling / methods. Specimen Handling / standards. Staining and Labeling / methods. Vimentin / analysis

  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15578068.001).
  • [ISSN] 0893-3952
  • [Journal-full-title] Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
  • [ISO-abbreviation] Mod. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Actins; 0 / Antigens, CD31; 0 / Antigens, CD34; 0 / Vimentin; 9001-27-8 / Factor VIII; EC 2.7.10.1 / Proto-Oncogene Proteins c-kit
  •  go-up   go-down


32. Sornmayura P, Howannapakorn J, Karnsombut P: Revision of gastrointestinal mesenchymal tumors. J Med Assoc Thai; 2009 Jan;92(1):87-95
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The previous diagnosis with smooth muscle tumor (leiomyoma or leiomyosarcoma) and nerve sheath tumor (schwannoma) become GISTs after the study with CD117 immunohistochemistry accompanying conventional histologic study in many series.
  • There were 33 cases previously diagnosed with leiomyosarcoma that became the diagnosis with GISTs (31 cases or 93.9%), due to CD117 positivity.
  • [MeSH-minor] Adult. Aged. Algorithms. Diagnosis, Differential. Female. Humans. Immunohistochemistry. Incidence. Male. Middle Aged. Prognosis. Retrospective Studies

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19260248.001).
  • [ISSN] 0125-2208
  • [Journal-full-title] Journal of the Medical Association of Thailand = Chotmaihet thangphaet
  • [ISO-abbreviation] J Med Assoc Thai
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Thailand
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; EC 2.7.10.1 / Proto-Oncogene Proteins c-kit
  •  go-up   go-down


33. Yoney A, Eren B, Eskici S, Salman A, Unsal M: Retrospective analysis of 105 cases with uterine sarcoma. Bull Cancer; 2008 Mar;95(3):E10-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Retrospective analysis of 105 cases with uterine sarcoma.
  • To evaluate the role of adjuvant therapy in survival and to identify important prognostic factors in uterine sarcoma.
  • One hundred five patients with uterine sarcoma have been retrospectively researched to evaluate the results in this tumor group.
  • 43.8% had leiomyosarcoma, 28.6% had endometrial stromal sarcoma and 27.6% had a malign Mullarian mixed tumor while the distribution according to the histological subgroups were found to be 42.6,16.2 and 41.2% in grade I, II and III tumors respectively.
  • Our data favors treatment for uterine sarcoma with radical surgery plus radiotherapy alone over 54 Gy or with chemotherapy.
  • [MeSH-major] Leiomyosarcoma. Mixed Tumor, Mullerian. Sarcoma, Endometrial Stromal. Uterine Neoplasms
  • [MeSH-minor] Adenosarcoma / mortality. Adenosarcoma / pathology. Adenosarcoma / secondary. Adenosarcoma / therapy. Adult. Aged. Aged, 80 and over. Analysis of Variance. Bone Neoplasms / secondary. Combined Modality Therapy. Disease-Free Survival. Female. Humans. Liver Neoplasms / secondary. Lung Neoplasms / secondary. Middle Aged. Neoplasm Recurrence, Local. Prognosis. Radiotherapy Dosage. Retrospective Studies. Survival Rate

  • Genetic Alliance. consumer health - Uterine sarcoma.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18390406.001).
  • [ISSN] 1769-6917
  • [Journal-full-title] Bulletin du cancer
  • [ISO-abbreviation] Bull Cancer
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article
  • [Publication-country] France
  •  go-up   go-down


34. Amant F, Coosemans A, Renard V, Everaert E, Vergote I: Clinical outcome of ET-743 (Trabectedin; Yondelis) in high-grade uterine sarcomas: report on five patients and a review of the literature. Int J Gynecol Cancer; 2009 Feb;19(2):245-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The clinical impact of ET-743 (trabectedin; Yondelis) in women with leiomyosarcoma and undifferentiated uterine sarcoma in patients previously treated with chemotherapy is investigated.
  • These results on the use of ET-743 in uterine sarcoma patients support the conductance of larger trials.
  • [MeSH-major] Antineoplastic Agents, Alkylating / administration & dosage. Dioxoles / administration & dosage. Sarcoma / drug therapy. Tetrahydroisoquinolines / administration & dosage. Uterine Neoplasms / drug therapy
  • [MeSH-minor] Adult. Female. Humans. Middle Aged. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19396002.001).
  • [ISSN] 1525-1438
  • [Journal-full-title] International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
  • [ISO-abbreviation] Int. J. Gynecol. Cancer
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents, Alkylating; 0 / Dioxoles; 0 / Tetrahydroisoquinolines; 114899-77-3 / trabectedin
  • [Number-of-references] 13
  •  go-up   go-down


35. Duff M, Dusenbery KE, Rodriguez FJ: Paraneoplastic encephalomyelitis: a case report and review of the literature. Gynecol Oncol; 2006 Sep;102(3):593-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Furthermore, paraneoplastic encephalomyelitis has never been reported to accompany a uterine leiomyosarcoma.
  • CASE: A 44-year-old female developed an ANNA-1 paraneoplastic encephalomyelitis after a diagnosis of a uterine leiomyosarcoma.
  • [MeSH-major] Leiomyosarcoma / complications. Paraneoplastic Syndromes, Nervous System / etiology. Uterine Neoplasms / complications
  • [MeSH-minor] Adult. Fatal Outcome. Female. Humans

  • Genetic Alliance. consumer health - Encephalomyelitis.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16677693.001).
  • [ISSN] 0090-8258
  • [Journal-full-title] Gynecologic oncology
  • [ISO-abbreviation] Gynecol. Oncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


36. Leung F, Terzibachian JJ, Gay C, Chung Fat B, Aouar Z, Lassabe C, Maillet R, Riethmuller D: [Hysterectomies performed for presumed leiomyomas: should the fear of leiomyosarcoma make us apprehend non laparotomic surgical routes?]. Gynecol Obstet Fertil; 2009 Feb;37(2):109-14
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Hysterectomies performed for presumed leiomyomas: should the fear of leiomyosarcoma make us apprehend non laparotomic surgical routes?].
  • OBJECTIVES: The presenting symptoms of leiomyosarcoma (LMS) are the same as those of leiomyoma.
  • However, given the extremely low incidence of LMS in series of hysterectomies performed for presumed leiomyomas and the lack of specific preoperative context to clearly evoke this diagnosis, the fear of leiomyosarcoma should not make us apprehend nonlaparotomic surgical routes.
  • [MeSH-major] Hysterectomy / methods. Leiomyoma / surgery. Leiomyosarcoma / surgery. Uterine Neoplasms / surgery
  • [MeSH-minor] Adult. Age Factors. Aged. Diagnosis, Differential. Female. Humans. Middle Aged. Retrospective Studies


37. Abadin SS, Korn JM, Worley TA, Podbielski FJ, Connolly MM: Cystic sarcoma of the psoas muscle masquerading as appendicitis. Am Surg; 2009 Sep;75(9):860-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cystic sarcoma of the psoas muscle masquerading as appendicitis.
  • [MeSH-major] Appendicitis / diagnosis. Leiomyosarcoma / diagnosis. Muscle Neoplasms / diagnosis. Psoas Muscles. Sarcoma / diagnosis
  • [MeSH-minor] Adult. Diagnosis, Differential. Humans. Male. Tomography, X-Ray Computed

  • MedlinePlus Health Information. consumer health - Appendicitis.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19774964.001).
  • [ISSN] 0003-1348
  • [Journal-full-title] The American surgeon
  • [ISO-abbreviation] Am Surg
  • [Language] eng
  • [Publication-type] Case Reports; Letter
  • [Publication-country] United States
  •  go-up   go-down


38. Vogl TJ, Lehnert T, Wetter A, Mack MG, Wurster MG: Interventional radiology in Carney triad. Eur Radiol; 2005 Apr;15(4):833-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Interventional therapeutic methods are presented in Carney triad, which is a syndrome defined as the simultaneous presence of gastric leiomyosarcoma, extra-adrenal paraganglioma, and pulmonary chondroma.
  • [MeSH-minor] Adult. Chondroma / radiography. Chondroma / therapy. Female. Humans. Leiomyosarcoma / radiography. Leiomyosarcoma / therapy. Paraganglioma / radiography. Paraganglioma / therapy

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15108016.001).
  • [ISSN] 0938-7994
  • [Journal-full-title] European radiology
  • [ISO-abbreviation] Eur Radiol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


39. Kokawa K, Nishiyama K, Ikeuchi M, Ihara Y, Akamatsu N, Enomoto T, Ishiko O, Motoyama S, Fujii S, Umesaki N: Clinical outcomes of uterine sarcomas: results from 14 years worth of experience in the Kinki district in Japan (1990-2003). Int J Gynecol Cancer; 2006 May-Jun;16(3):1358-63
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Uterine sarcomas were defined as leiomyosarcoma (LMS), endometrial stromal sarcoma (ESS), and carcinosarcoma (CS).
  • [MeSH-major] Sarcoma / diagnosis. Sarcoma / therapy. Uterine Neoplasms / diagnosis. Uterine Neoplasms / therapy
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Chemotherapy, Adjuvant / methods. Combined Modality Therapy / methods. Disease-Free Survival. Female. Humans. Hysterectomy / statistics & numerical data. Japan. Lymph Node Excision / statistics & numerical data. Middle Aged. Retrospective Studies. Survival Rate. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16803530.001).
  • [ISSN] 1048-891X
  • [Journal-full-title] International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
  • [ISO-abbreviation] Int. J. Gynecol. Cancer
  • [Language] eng
  • [Publication-type] Journal Article; Multicenter Study
  • [Publication-country] United States
  •  go-up   go-down


40. Staiano JJ, Wong L, Butler J, Searle AE, Barton DP, Harris PA: Flap reconstruction following gynaecological tumour resection for advanced and recurrent disease--a 12 year experience. J Plast Reconstr Aesthet Surg; 2009 Mar;62(3):346-51
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Squamous cell carcinoma was the most common histological type, accounting for 71% of cases, with adenocarcinoma, Paget disease, leiomyosarcoma, melanoma and basosquamous carcinoma making up the remainder.
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Female. Humans. Middle Aged. Neoplasm Recurrence, Local / surgery. Retrospective Studies. Surgical Wound Infection / prevention & control. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18784004.001).
  • [ISSN] 1878-0539
  • [Journal-full-title] Journal of plastic, reconstructive & aesthetic surgery : JPRAS
  • [ISO-abbreviation] J Plast Reconstr Aesthet Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


41. Herawi M, Montgomery EA, Epstein JI: Gastrointestinal stromal tumors (GISTs) on prostate needle biopsy: A clinicopathologic study of 8 cases. Am J Surg Pathol; 2006 Nov;30(11):1389-95
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • One should consider CD117/c-kit in the immunohistochemical panel to exclude GIST before diagnosing a solitary fibrous tumor, leiomyosarcoma, or specialized prostatic stromal tumor on prostate needle biopsy.
  • [MeSH-minor] Adult. Aged. Antineoplastic Agents / therapeutic use. Benzamides. Biopsy, Needle. Combined Modality Therapy. Diagnosis, Differential. Digestive System Surgical Procedures. Humans. Imatinib Mesylate. Immunohistochemistry. Male. Middle Aged. Piperazines / therapeutic use. Prostatic Neoplasms / pathology. Pyrimidines / therapeutic use

  • Genetic Alliance. consumer health - Gastrointestinal Stromal Tumors.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. IMATINIB MESYLATE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17063078.001).
  • [ISSN] 0147-5185
  • [Journal-full-title] The American journal of surgical pathology
  • [ISO-abbreviation] Am. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Benzamides; 0 / Piperazines; 0 / Pyrimidines; 8A1O1M485B / Imatinib Mesylate
  •  go-up   go-down


42. Robles R, Marín C, Abellán B, López A, Pastor P, Parrilla P: A new approach to hand-assisted laparoscopic liver surgery. Surg Endosc; 2008 Nov;22(11):2357-64
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: We performed 35 laparoscopic resections in SLTs, of which 26 were carried out using HALS (in 25 patients) and 21 patients had liver metastases of a colorectal origin (LMCRC) (1 patient had 2 resections), 1 metastasis from a neuroendocrine tumour of the pancreas, 1 hepatocarcinoma on a healthy liver, 1 primary hepatic leiomyosarcoma and 1 giant haemangioma.
  • [MeSH-minor] Adult. Aged. Blood Loss, Surgical / statistics & numerical data. Blood Transfusion / statistics & numerical data. Colorectal Neoplasms / pathology. Female. Humans. Length of Stay / statistics & numerical data. Liver Neoplasms / secondary. Liver Neoplasms / surgery. Male. Middle Aged. Postoperative Complications / epidemiology. Survival Rate. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Arch Surg. 1997 Feb;132(2):166-8; discussion 169 [9041921.001]
  • [Cites] Cir Esp. 2005 Jul;78(1):19-27 [16420786.001]
  • [Cites] J Gastrointest Surg. 2004 Feb;8(2):213-6 [15036198.001]
  • [Cites] J Hepatobiliary Pancreat Surg. 2003;10(4):295-8 [14598149.001]
  • [Cites] Surg Laparosc Endosc Percutan Tech. 2003 Aug;13(4):276-9 [12960793.001]
  • [Cites] Ann Surg. 2006 Apr;243(4):499-506 [16552201.001]
  • [Cites] Ann Surg. 1999 Apr;229(4):460-6 [10203077.001]
  • [Cites] Am J Surg. 2005 Feb;189(2):190-4 [15720988.001]
  • [Cites] J Am Coll Surg. 2005 Mar;200(3):472-80 [15737861.001]
  • [Cites] Surg Endosc. 2005 Jul;19(7):886-91 [15920694.001]
  • [Cites] Ann Surg. 2006 Nov;244(5):815-20 [17060776.001]
  • [Cites] Hepatogastroenterology. 2002 May-Jun;49(45):803-5 [12063994.001]
  • [Cites] Ann Surg. 1998 Mar;227(3):326-34 [9527054.001]
  • [Cites] Semin Laparosc Surg. 2001 Jun;8(2):104-13 [11441399.001]
  • [Cites] Br J Surg. 2003 Jun;90(6):644-6 [12808610.001]
  • [Cites] Br J Surg. 2007 Jan;94(1):58-63 [17054316.001]
  • [Cites] Am J Surg. 2005 Apr;189(4):474-8 [15820465.001]
  • [Cites] Ann Surg. 2002 Jul;236(1):90-7 [12131090.001]
  • [Cites] Surg Endosc. 2001 Aug;15(8):794-8 [11443467.001]
  • [Cites] Surg Endosc. 2003 Dec;17(12):1914-8 [14574547.001]
  • [Cites] Arch Surg. 2002 Apr;137(4):407-11; discussion 412 [11926943.001]
  • [Cites] Ann Surg. 1999 Apr;229(4):487-92 [10203080.001]
  • [Cites] Ann Surg. 2000 Nov;232(5):641-5 [11066134.001]
  • [Cites] Surg Endosc. 2003 Jan;17(1):23-30 [12364994.001]
  • [Cites] Am J Transplant. 2006 Oct;6(10):2522-5 [16889605.001]
  • [Cites] J Hepatobiliary Pancreat Surg. 2005;12(4):298-303 [16133696.001]
  • [Cites] Br J Surg. 1999 Nov;86(11):1397-400 [10583285.001]
  • [Cites] Surg Laparosc Endosc Percutan Tech. 2002 Oct;12(5):325-30 [12409698.001]
  • [Cites] J Hepatobiliary Pancreat Surg. 2002;9(2):242-8 [12140614.001]
  • [Cites] Br J Surg. 2006 Jan;93(1):67-72 [16273531.001]
  • [Cites] Surg Endosc. 1996 Jul;10(7):758-61 [8662435.001]
  • [Cites] Ann Surg. 2000 Dec;232(6):753-62 [11088070.001]
  • [Cites] Br J Surg. 1998 Jun;85(6):735-41 [9667697.001]
  • [Cites] Cir Esp. 2005 Sep;78(3):152-60 [16420816.001]
  • [Cites] Br J Surg. 1996 Oct;83(10):1419-20 [8944461.001]
  • [Cites] Surg Endosc. 2006 Oct;20(10):1531-5 [16865612.001]
  • [Cites] Arch Surg. 2000 Jul;135(7):854-9 [10896382.001]
  • [Cites] Cir Esp. 2005 Oct;78(4):238-45 [16420832.001]
  • [Cites] Br J Surg. 1996 Mar;83(3):334-5 [8665184.001]
  • [Cites] J Am Coll Surg. 2003 Feb;196(2):236-42 [12595052.001]
  • [Cites] Ann Surg. 2003 Nov;238(5):674-9 [14578728.001]
  • (PMID = 18322747.001).
  • [ISSN] 1432-2218
  • [Journal-full-title] Surgical endoscopy
  • [ISO-abbreviation] Surg Endosc
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


43. Martínez-Morán C, Moreno A, Miñano R, Romero-Maté A, Tardío JC, Borbujo JM: Cutaneous leiomyosarcoma and intramuscular myxoid liposarcoma in a patient with hereditary retinoblastoma. Int J Dermatol; 2010 May;49(5):570-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cutaneous leiomyosarcoma and intramuscular myxoid liposarcoma in a patient with hereditary retinoblastoma.
  • [MeSH-major] Leiomyosarcoma / diagnosis. Liposarcoma, Myxoid / diagnosis. Muscle Neoplasms / diagnosis. Skin Neoplasms / diagnosis
  • [MeSH-minor] Adult. Female. Humans. Retinoblastoma / complications. Retinoblastoma / pathology


44. Bouaziz MC, Chaabane S, Mrad K, Oueslati S, Bellassoued A, Ladeb MF, Rhomdhane KB: Primary leiomyosarcoma of bone: report of 4 cases. J Comput Assist Tomogr; 2005 Mar-Apr;29(2):254-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary leiomyosarcoma of bone: report of 4 cases.
  • Primary leiomyosarcoma of bone is a very rare tumor.
  • [MeSH-major] Bone Neoplasms / diagnosis. Femoral Neoplasms / diagnosis. Image Processing, Computer-Assisted. Leiomyosarcoma / diagnosis. Magnetic Resonance Imaging. Talus. Tomography, X-Ray Computed
  • [MeSH-minor] Adult. Aged. Amputation. Biomarkers, Tumor / analysis. Biopsy. Diagnosis, Differential. Female. Follow-Up Studies. Humans. Lung Neoplasms / pathology. Lung Neoplasms / secondary. Lung Neoplasms / surgery. Male. Middle Aged. Neoplasm Recurrence, Local / diagnosis. Neoplasm Recurrence, Local / pathology. Neoplasm Recurrence, Local / surgery. Osteolysis / diagnosis. Osteolysis / pathology. Reoperation

  • Genetic Alliance. consumer health - Leiomyosarcoma.
  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • MedlinePlus Health Information. consumer health - CT Scans.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15772548.001).
  • [ISSN] 0363-8715
  • [Journal-full-title] Journal of computer assisted tomography
  • [ISO-abbreviation] J Comput Assist Tomogr
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


45. Damjanov I, Fan F: Chondrosarcomatous differentiation of a metastatic leiomyosarcoma of the uterus. Virchows Arch; 2006 Oct;449(4):493-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Chondrosarcomatous differentiation of a metastatic leiomyosarcoma of the uterus.
  • [MeSH-major] Chondrosarcoma / pathology. Leiomyosarcoma / secondary. Neoplasms, Second Primary. Soft Tissue Neoplasms / secondary. Uterine Neoplasms / pathology
  • [MeSH-minor] Actins / analysis. Adult. Biomarkers, Tumor / analysis. Cell Transformation, Neoplastic. Desmin / analysis. Female. Humans. Hysterectomy. Neoplasm Metastasis. Radiotherapy, Adjuvant. S100 Proteins / analysis

  • Genetic Alliance. consumer health - Leiomyosarcoma.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentOn] Virchows Arch. 2006 Jan;448(1):85-9 [16228225.001]
  • [Cites] Gynecol Oncol. 2004 Dec;95(3):712-5 [15581987.001]
  • [Cites] Virchows Arch. 2006 Jan;448(1):85-9 [16228225.001]
  • [Cites] Virchows Arch. 1994;424(5):539-45 [8032534.001]
  • (PMID = 16912880.001).
  • [ISSN] 0945-6317
  • [Journal-full-title] Virchows Archiv : an international journal of pathology
  • [ISO-abbreviation] Virchows Arch.
  • [Language] eng
  • [Publication-type] Case Reports; Comment; Letter
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Actins; 0 / Biomarkers, Tumor; 0 / Desmin; 0 / S100 Proteins
  •  go-up   go-down


46. McMeekin DS, Sill MW, Darcy KM, Stearns-Kurosawa DJ, Webster K, Waggoner S, Benbrook D: A phase II trial of thalidomide in patients with refractory leiomyosarcoma of the uterus and correlation with biomarkers of angiogenesis: a gynecologic oncology group study. Gynecol Oncol; 2007 Sep;106(3):596-603
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A phase II trial of thalidomide in patients with refractory leiomyosarcoma of the uterus and correlation with biomarkers of angiogenesis: a gynecologic oncology group study.
  • OBJECTIVES: To evaluate the efficacy and adverse events (AEs) of thalidomide in previously treated, measurable, persistent or recurrent leiomyosarcoma (LMS) of the uterus, and to explore associations between angiogenic markers and treatment or clinical outcome.
  • [MeSH-major] Angiogenesis Inhibitors / therapeutic use. Leiomyosarcoma / blood supply. Leiomyosarcoma / drug therapy. Thalidomide / therapeutic use. Uterine Neoplasms / blood supply. Uterine Neoplasms / drug therapy
  • [MeSH-minor] Adult. Aged. Antigens, CD / blood. Biomarkers, Tumor / blood. Dose-Response Relationship, Drug. Female. Fibroblast Growth Factor 2 / blood. Humans. Middle Aged. Neoplasm Recurrence, Local / blood supply. Neoplasm Recurrence, Local / drug therapy. Neovascularization, Pathologic / blood. Neovascularization, Pathologic / drug therapy. Proportional Hazards Models. Receptors, Cell Surface / blood. Vascular Endothelial Growth Factor A / blood

  • Genetic Alliance. consumer health - Leiomyosarcoma.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • Hazardous Substances Data Bank. THALIDOMIDE .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17597196.001).
  • [ISSN] 0090-8258
  • [Journal-full-title] Gynecologic oncology
  • [ISO-abbreviation] Gynecol. Oncol.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / CA 27469; United States / NCI NIH HHS / CA / CA 37517
  • [Publication-type] Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Angiogenesis Inhibitors; 0 / Antigens, CD; 0 / Biomarkers, Tumor; 0 / PROCR protein, human; 0 / Receptors, Cell Surface; 0 / Vascular Endothelial Growth Factor A; 103107-01-3 / Fibroblast Growth Factor 2; 4Z8R6ORS6L / Thalidomide
  •  go-up   go-down


47. Kim CH, Dancer JY, Coffey D, Zhai QJ, Reardon M, Ayala AG, Ro JY: Clinicopathologic study of 24 patients with primary cardiac sarcomas: a 10-year single institution experience. Hum Pathol; 2008 Jun;39(6):933-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We present a 10-year, single-institution experience with 24 primary adult cardiac sarcomas.
  • In conclusion, angiosarcoma and unclassified sarcomas are the most common sarcomas of the heart accounting for 76%, but rare tumors such as synovial sarcoma and leiomyosarcoma may also occur in this organ.
  • [MeSH-minor] Adult. Aged. Biomarkers, Tumor / analysis. Combined Modality Therapy. Female. Humans. Male. Middle Aged. Neoplasm Recurrence, Local. Survival Rate

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18538171.001).
  • [ISSN] 1532-8392
  • [Journal-full-title] Human pathology
  • [ISO-abbreviation] Hum. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


48. Mezghani S, Abdelghani A, Trabelsi A, Hayouni A, Garrouche A, Benzarti M, Jerray M: [Large bilateral lung opacities]. Rev Pneumol Clin; 2005 Dec;61(6):387-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Biopsy of one of these masses was in favor of secondary or primary leiomyosarcoma.
  • The association of Von Recklinghausen's disease and soft tissue sarcoma is rare: most often neurofibroma which degenerates is observed.
  • Other types of sarcoma, like leiomyosarcoma, have been described.
  • [MeSH-major] Leiomyosarcoma / pathology. Lung Neoplasms / pathology. Neurofibromatosis 1 / pathology
  • [MeSH-minor] Adult. Biopsy. Chest Pain / etiology. Comorbidity. Female. Functional Laterality. Humans. Neoplasms, Second Primary. Radiography, Thoracic. Scalp / pathology. Tomography, X-Ray Computed

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16449930.001).
  • [ISSN] 0761-8417
  • [Journal-full-title] Revue de pneumologie clinique
  • [ISO-abbreviation] Rev Pneumol Clin
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


49. Cameron S, Ramadori G, Füzesi L, Sattler B, Gunawan B, Müller D, Ringe B, Lorf T: Successful liver transplantation in two cases of metastatic gastrointestinal stromal tumors. Transplantation; 2005 Jul 27;80(2):283-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Leiomyosarcoma / pathology. Liver Neoplasms / secondary. Liver Transplantation. Stomach Neoplasms / pathology
  • [MeSH-minor] Adult. Female. Humans. Male. Tomography, X-Ray Computed. Treatment Outcome


50. Kleisli T, Raissi SS, Nissen NN, Cheng W, Cohen L, Sacks SA, Trento A: Cavo-atrial tumor resection under total circulatory arrest without a sternotomy. Ann Thorac Surg; 2006 May;81(5):1887-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-minor] Adult. Aged. Female. Heart Arrest, Induced. Heart Atria. Humans. Leiomyosarcoma / pathology. Leiomyosarcoma / surgery. Male. Middle Aged. Neoplasm Invasiveness

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16631697.001).
  • [ISSN] 1552-6259
  • [Journal-full-title] The Annals of thoracic surgery
  • [ISO-abbreviation] Ann. Thorac. Surg.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


51. Liao CH, Lai MK, Li HY, Chen SC, Chueh SC: Laparoscopic adrenalectomy using needlescopic instruments for adrenal tumors less than 5cm in 112 cases. Eur Urol; 2008 Sep;54(3):640-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Except for one leiomyosarcoma, all other tumors were benign adrenal pathologies (57 aldosterone-producing adenomas, 23 Cushing's adenomas, 12 pheochromocytomas, and 20 incidentalomas).
  • [MeSH-minor] Adult. Aged. Analysis of Variance. Female. Humans. Linear Models. Male. Middle Aged. Statistics, Nonparametric. Treatment Outcome

  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Eur Urol. 2008 Sep;54(3):493-5; author reply 495-7 [18281144.001]
  • [CommentIn] Nat Clin Pract Urol. 2009 Jan;6(1):10-1 [19048004.001]
  • (PMID = 18164803.001).
  • [ISSN] 0302-2838
  • [Journal-full-title] European urology
  • [ISO-abbreviation] Eur. Urol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Switzerland
  •  go-up   go-down


52. Chen HJ, Xu M, Zhang L, Zhang YK, Wang GM: [Prostate sarcoma: a report of 14 cases]. Zhonghua Nan Ke Xue; 2005 Sep;11(9):683-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Prostate sarcoma: a report of 14 cases].
  • OBJECTIVE: To discuss the diagnosis and effective treatment of prostate sarcoma.
  • METHODS: We analysed the clinical materials of fourteen patients with prostate sarcoma treated in our hospital from Jan.
  • RESULTS: Prostate sarcoma accounted for 3.21% of all the prostatic malignant tumors treated in our hospital during that period.
  • Pathological test revealed: 7 cases leiomyosarcoma, 1 case rhabdomyosarcoma, 4 cases fibrosarcoma, 2 cases spindle cell sarcoma.
  • Different kinds of prostate sarcoma each his its own immuno-histochemical staining features.
  • CONCLUSION: Dysuria is always the first symptom of prostate sarcoma.
  • DRE test may suggest prostate sarcoma but needle biopsy contributes to a definite diagnosis.
  • The prognosis of prostate sarcoma is very poor and the main treatment is surgery followed by chemotherapy and/or radiotherapy.
  • [MeSH-major] Prostatic Neoplasms / diagnosis. Prostatic Neoplasms / therapy. Sarcoma / diagnosis. Sarcoma / therapy
  • [MeSH-minor] Adolescent. Adult. Biopsy, Needle. Follow-Up Studies. Humans. Immunohistochemistry. Male. Middle Aged. Neoplasm Staging. Prognosis


53. Garraud M, Margery J, Laborde F, Saint-Blancard P, David S, Bonardel G, Héno P: [Pulmonary vein leiomyosarcoma extending into the left atrium]. Rev Pneumol Clin; 2010 Oct;66(5):321-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Pulmonary vein leiomyosarcoma extending into the left atrium].
  • In this paper, the authors report the case of a 28-year-old man with pulmonary vein leiomyosarcoma presenting subacute respiratory distress.
  • Emergency cardiac surgery revealed the mass to be a leiomyosarcoma, probably extending from the right inferior pulmonary vein and extending into the left atrium.
  • [MeSH-major] Heart Atria / pathology. Heart Neoplasms / pathology. Leiomyosarcoma / diagnosis. Pulmonary Veins / pathology. Vascular Neoplasms / diagnosis
  • [MeSH-minor] Adult. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Chemotherapy, Adjuvant. Echocardiography, Transesophageal. Fatal Outcome. Humans. Male. Military Personnel. Mitral Valve / pathology. Neoadjuvant Therapy. Neoplasm Recurrence, Local / pathology. Pulmonary Edema / diagnosis. Respiratory Insufficiency / diagnosis. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Leiomyosarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 Elsevier Masson SAS. All rights reserved.
  • (PMID = 21087728.001).
  • [ISSN] 0761-8417
  • [Journal-full-title] Revue de pneumologie clinique
  • [ISO-abbreviation] Rev Pneumol Clin
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


54. Gogou PN, Batistatou A, Pakos EE, Apostolikas N, Stefanou D, Tsekeris PG: Expression of E-cadherin, beta-catenin and topoisomerase IIalpha in leiomyosarcomas. Clin Transl Oncol; 2009 Aug;11(8):548-51
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Antigens, Neoplasm / metabolism. Cadherins / metabolism. DNA Topoisomerases, Type II / metabolism. DNA-Binding Proteins / metabolism. Leiomyosarcoma / metabolism. beta Catenin / metabolism
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Female. Humans. Immunohistochemistry. Male. Middle Aged

  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Pathol. 2000 Nov;192(3):342-50 [11054718.001]
  • [Cites] Cancer. 2008 Jul 1;113(1):97-107 [18473353.001]
  • [Cites] Virchows Arch. 2003 Jun;442(6):529-37 [12743815.001]
  • [Cites] Curr Opin Genet Dev. 2003 Feb;13(1):28-33 [12573432.001]
  • [Cites] Hum Pathol. 2008 Jun;39(6):837-45 [18400250.001]
  • [Cites] Mod Pathol. 2005 Jan;18(1):68-74 [15375433.001]
  • [Cites] J Clin Oncol. 2006 Apr 1;24(10 ):1546-53 [16575006.001]
  • [Cites] Arch Pathol Lab Med. 2002 Jan;126(1):33-8 [11800644.001]
  • [Cites] Mod Pathol. 1997 Sep;10(9):901-7 [9310953.001]
  • [Cites] Hum Pathol. 2001 Mar;32(3):257-63 [11274633.001]
  • [Cites] Genes Dev. 2006 Dec 1;20(23):3199-214 [17158740.001]
  • [Cites] Oncol Rep. 2008 Feb;19(2):377-83 [18202784.001]
  • [Cites] Pathol Int. 2004 Mar;54(3):145-50 [14989736.001]
  • [Cites] Science. 1991 Mar 22;251(5000):1451-5 [2006419.001]
  • [Cites] Am J Surg Pathol. 2005 May;29(5):653-9 [15832090.001]
  • [Cites] Histopathology. 2007 Oct;51(4):509-14 [17711447.001]
  • [Cites] J Pathol. 1997 Jun;182(2):128-37 [9274521.001]
  • [Cites] Mod Pathol. 1998 Feb;11(2):186-93 [9504690.001]
  • [Cites] Hum Pathol. 1999 Nov;30(11):1344-9 [10571515.001]
  • [Cites] Mod Pathol. 2000 May;13(5):542-7 [10824926.001]
  • (PMID = 19661031.001).
  • [ISSN] 1699-3055
  • [Journal-full-title] Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
  • [ISO-abbreviation] Clin Transl Oncol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Italy
  • [Chemical-registry-number] 0 / Antigens, Neoplasm; 0 / Cadherins; 0 / DNA-Binding Proteins; 0 / beta Catenin; EC 5.99.1.3 / DNA Topoisomerases, Type II; EC 5.99.1.3 / DNA topoisomerase II alpha
  •  go-up   go-down


55. Leiser AL, Anderson SE, Nonaka D, Chuai S, Olshen AB, Chi DS, Soslow RA: Apoptotic and cell cycle regulatory markers in uterine leiomyosarcoma. Gynecol Oncol; 2006 Apr;101(1):86-91
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Apoptotic and cell cycle regulatory markers in uterine leiomyosarcoma.
  • OBJECTIVES: The primary aim of this study was to investigate the expression of apoptotic and cell cycle regulators p53, p21, p27, bax, and bcl-2 in uterine leiomyosarcoma in order to identify molecular pathways that possibly could be important in the development of leiomyosarcoma.
  • A secondary aim was to examine if the apoptotic and cell cycle regulatory protein expression profile of uterine leiomyosarcoma is potentially useful for clinical prognostic purposes.
  • RESULTS: Associations were found between disease type (leiomyosarcoma vs. leiomyoma) and the positivity status of p21 (43% vs. 0%, P < 0.001), p53 (54% vs. 0%, P < 0.001), and bax (34% vs. 94%, P < 0.001).
  • bcl-2-positive leiomyosarcoma was associated with a longer time to recurrence (P = 0.02) in a univariate analysis.
  • CONCLUSION: The significant differential expression of apoptotic and cell cycle regulatory proteins in uterine leiomyosarcoma as compared to benign smooth muscle tumors suggests that pathways involving these proteins may be important in the development of malignant disease and, therefore, could be potential targets for molecular therapies.
  • [MeSH-major] Apoptosis / physiology. Biomarkers, Tumor / biosynthesis. Cell Cycle / physiology. Cell Cycle Proteins / biosynthesis. Leiomyosarcoma / metabolism. Leiomyosarcoma / pathology. Uterine Neoplasms / metabolism. Uterine Neoplasms / pathology
  • [MeSH-minor] Adult. Aged. Female. Humans. Immunohistochemistry. Middle Aged. Neoplasm Staging. Prognosis. Survival Rate

  • Genetic Alliance. consumer health - Leiomyosarcoma.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16289259.001).
  • [ISSN] 0090-8258
  • [Journal-full-title] Gynecologic oncology
  • [ISO-abbreviation] Gynecol. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Cell Cycle Proteins
  •  go-up   go-down


56. O'Cearbhaill R, Zhou Q, Iasonos A, Soslow RA, Leitao MM, Aghajanian C, Hensley ML: Treatment of advanced uterine leiomyosarcoma with aromatase inhibitors. Gynecol Oncol; 2010 Mar;116(3):424-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Treatment of advanced uterine leiomyosarcoma with aromatase inhibitors.
  • BACKGROUND: Aromatase inhibitors are sometimes used in the treatment of selected patients with uterine leiomyosarcoma (LMS), but there are few data assessing the efficacy of aromatase inhibitors in this setting.
  • [MeSH-major] Aromatase Inhibitors / therapeutic use. Leiomyosarcoma / drug therapy. Uterine Neoplasms / drug therapy
  • [MeSH-minor] Adult. Aged. Chemotherapy, Adjuvant. Cohort Studies. Disease-Free Survival. Female. Humans. Middle Aged. Neoplasm Recurrence, Local / drug therapy. Neoplasm Recurrence, Local / enzymology. Neoplasm Recurrence, Local / metabolism. Receptors, Estrogen / metabolism. Receptors, Progesterone / metabolism. Retrospective Studies

  • Genetic Alliance. consumer health - Leiomyosarcoma.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19932916.001).
  • [ISSN] 1095-6859
  • [Journal-full-title] Gynecologic oncology
  • [ISO-abbreviation] Gynecol. Oncol.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / P30 CA008748
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Aromatase Inhibitors; 0 / Receptors, Estrogen; 0 / Receptors, Progesterone
  • [Other-IDs] NLM/ NIHMS774762; NLM/ PMC4852374
  •  go-up   go-down


57. Nilbert M, Therkildsen C, Nissen A, Akerman M, Bernstein I: Sarcomas associated with hereditary nonpolyposis colorectal cancer: broad anatomical and morphological spectrum. Fam Cancer; 2009;8(3):209-13
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The median age at sarcoma diagnosis was 43 (15-74) years.
  • Soft tissue sarcomas predominated followed by uterine sarcomas and eight histopathological subtypes were represented with recurrent diagnoses of liposarcoma, leiomyosarcoma, and carcinosarcoma.
  • This suggests that sarcomas may be part of the HNPCC tumor spectrum and that colorectal cancer should be considered in the family history of sarcoma patients.
  • [MeSH-major] Colorectal Neoplasms, Hereditary Nonpolyposis / genetics. MutS Homolog 2 Protein / genetics. Sarcoma / genetics
  • [MeSH-minor] Adolescent. Adult. Aged. Colorectal Neoplasms / genetics. DNA Mismatch Repair. DNA Repair Enzymes / genetics. DNA-Binding Proteins / genetics. Endometrial Neoplasms / genetics. Female. Humans. Male. Middle Aged. Young Adult

  • Genetic Alliance. consumer health - Colorectal Cancer.
  • Genetic Alliance. consumer health - Hereditary Cancer.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Fam Cancer. 2008;7(2):163-72 [17939062.001]
  • [Cites] Am J Gastroenterol. 2006 Jan;101(1):193-6 [16405554.001]
  • [Cites] Int J Cancer. 2008 Jul 15;123(2):444-449 [18398828.001]
  • [Cites] Gastroenterology. 1999 Jun;116(6):1453-6 [10348829.001]
  • [Cites] Fam Cancer. 2009;8(1):75-83 [18566915.001]
  • [Cites] Nat Rev Cancer. 2003 Sep;3(9):685-94 [12951587.001]
  • [Cites] Dis Colon Rectum. 1998 Apr;41(4):428-33 [9559626.001]
  • [Cites] Cancer. 2003 Nov 1;98(9):1947-57 [14584079.001]
  • [Cites] Clin Genet. 2008 Sep;74(3):233-42 [18554281.001]
  • [Cites] Histopathology. 2003 Sep;43(3):297-9 [12940783.001]
  • [Cites] Genes Chromosomes Cancer. 2000 Dec;29(4):353-5 [11066081.001]
  • [Cites] Mod Pathol. 2004 Aug;17 (8):981-9 [15143336.001]
  • [Cites] Obstet Gynecol. 2007 Aug;110(2 Pt 2):543-5 [17666659.001]
  • [Cites] Ann Oncol. 2002 May;13(5):807-8 [12075754.001]
  • [Cites] Int J Cancer. 1999 Apr 12;81(2):214-8 [10188721.001]
  • (PMID = 19130300.001).
  • [ISSN] 1573-7292
  • [Journal-full-title] Familial cancer
  • [ISO-abbreviation] Fam. Cancer
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / DNA-Binding Proteins; 0 / G-T mismatch-binding protein; EC 3.6.1.3 / MutS Homolog 2 Protein; EC 6.5.1.- / DNA Repair Enzymes
  •  go-up   go-down


58. Biró ZJ, Kalmár Nagy K, Fehér E, Gömöri E, Horváth OP: [Surgical treatment of primary leiomyosarcoma of the inferior vena cava]. Magy Seb; 2009 Apr;62(2):83-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Surgical treatment of primary leiomyosarcoma of the inferior vena cava].
  • [Transliterated title] Primer vena cava inferior leiomyosarcoma (VCI-LMS) sebészi kezelése.
  • DISCUSSION: Primary leiomyosarcoma of the inferior vena cava (pLMS-IVC) is an extremely rare form of retroperitoneal malignancies.
  • [MeSH-major] Leiomyosarcoma / diagnosis. Leiomyosarcoma / therapy. Neoplasm Recurrence, Local / surgery. Retroperitoneal Neoplasms / diagnosis. Retroperitoneal Neoplasms / therapy. Vascular Neoplasms / diagnosis. Vascular Neoplasms / therapy. Vena Cava, Inferior
  • [MeSH-minor] Adult. Female. Humans. Lymph Node Excision. Prognosis. Reoperation

  • Genetic Alliance. consumer health - Leiomyosarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19386569.001).
  • [ISSN] 0025-0295
  • [Journal-full-title] Magyar sebészet
  • [ISO-abbreviation] Magy Seb
  • [Language] hun
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Hungary
  •  go-up   go-down


59. Blay JY, von Mehren M, Samuels BL, Fanucchi MP, Ray-Coquard I, Buckley B, Gilles L, Lebedinsky C, Elsayed YA, Le Cesne A: Phase I combination study of trabectedin and doxorubicin in patients with soft-tissue sarcoma. Clin Cancer Res; 2008 Oct 15;14(20):6656-62
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Phase I combination study of trabectedin and doxorubicin in patients with soft-tissue sarcoma.
  • PURPOSE: To determine the dose of trabectedin plus doxorubicin with granulocyte colony-stimulating factor support associated with manageable neutropenia and acceptable dose-limiting toxicities (DLT) in patients with recurrent or persistent soft-tissue sarcoma.
  • CONCLUSION: The combination of doxorubicin 60 mg/m(2) followed by trabectedin 1.1 mg/m(2) every 21 days is safe and active in patients with soft-tissue sarcoma.

  • Genetic Alliance. consumer health - Soft tissue sarcoma.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. DOXORUBICIN .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Clin Oncol. 2005 Aug 20;23(24):5484-92 [16110008.001]
  • [Cites] J Clin Oncol. 2005 Mar 20;23(9):1867-74 [15774779.001]
  • [Cites] Cancer Radiother. 2006 Jun;10(4):185-207 [16917992.001]
  • [Cites] Lancet Oncol. 2007 Jul;8(7):595-602 [17586092.001]
  • [Cites] Clin Cancer Res. 2001 Feb;7(2):231-42 [11234874.001]
  • [Cites] J Clin Oncol. 2001 Mar 1;19(5):1248-55 [11230465.001]
  • [Cites] J Clin Oncol. 2001 Mar 1;19(5):1256-65 [11230466.001]
  • [Cites] Int J Cancer. 2001 May 15;92(4):583-8 [11304695.001]
  • [Cites] Eur J Cancer. 2001 May;37(7):870-7 [11313175.001]
  • [Cites] Nat Med. 2001 Aug;7(8):961-6 [11479630.001]
  • [Cites] Clin Cancer Res. 2001 Sep;7(9):2908-11 [11555609.001]
  • [Cites] Clin Cancer Res. 2001 Oct;7(10):3251-7 [11595721.001]
  • [Cites] Chem Biol. 2001 Dec;8(12):1151-60 [11755394.001]
  • [Cites] Clin Cancer Res. 2002 Jan;8(1):75-85 [11801542.001]
  • [Cites] Eur J Cancer. 2002 Mar;38(4):543-9 [11872347.001]
  • [Cites] Cancer Chemother Pharmacol. 2003 Aug;52(2):131-8 [12783202.001]
  • [Cites] Cancer. 2003 Aug 15;98(4):832-40 [12910529.001]
  • [Cites] J Clin Oncol. 2004 Mar 1;22(5):890-9 [14990645.001]
  • [Cites] J Clin Oncol. 2004 Apr 15;22(8):1480-90 [15084621.001]
  • [Cites] Cancer. 1973 Jul;32(1):1-8 [4716773.001]
  • [Cites] J Clin Oncol. 1993 Jul;11(7):1269-75 [8315424.001]
  • [Cites] J Clin Oncol. 1995 Jul;13(7):1537-45 [7602342.001]
  • [Cites] Biochemistry. 1996 Oct 15;35(41):13303-9 [8873596.001]
  • [Cites] Ann Oncol. 1998 Sep;9(9):981-7 [9818072.001]
  • [Cites] J Med Chem. 1999 Jul 15;42(14):2493-7 [10411470.001]
  • [Cites] J Clin Oncol. 2005 Jan 20;23(3):576-84 [15659504.001]
  • [Cites] J Natl Cancer Inst. 2000 Feb 2;92(3):205-16 [10655437.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6780-4 [10841573.001]
  • [Cites] Br J Cancer. 2006 Jun 5;94(11):1610-4 [16736024.001]
  • (PMID = 18927308.001).
  • [ISSN] 1078-0432
  • [Journal-full-title] Clinical cancer research : an official journal of the American Association for Cancer Research
  • [ISO-abbreviation] Clin. Cancer Res.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / P30 CA006927; None / None / / P30 CA006927-46; United States / NCI NIH HHS / CA / P30 CA006927-46
  • [Publication-type] Clinical Trial, Phase I; Journal Article; Multicenter Study
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Dioxoles; 0 / Tetrahydroisoquinolines; 114899-77-3 / trabectedin; 143011-72-7 / Granulocyte Colony-Stimulating Factor; 80168379AG / Doxorubicin
  • [Other-IDs] NLM/ NIHMS113333; NLM/ PMC2777645
  •  go-up   go-down


60. Chen HK, Huang HY, Li CF, Ko SF, Changchien CC, Chen WJ, Huang CC: Synchronous presentation of uterine leiomyosarcoma and retroperitoneal liposarcoma: analysis by comparative genomic hybridization and review of the literature. Int J Gynecol Pathol; 2009 Nov;28(6):535-40
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Synchronous presentation of uterine leiomyosarcoma and retroperitoneal liposarcoma: analysis by comparative genomic hybridization and review of the literature.
  • We encountered a patient presenting with a uterine sarcoma and another retroperitoneal mass at the same time.
  • The diagnosis of a synchronous presentation of a uterine leiomyosarcoma and a retroperitoneal sclerosing well-differentiated liposarcoma was rendered.
  • [MeSH-major] Leiomyosarcoma / pathology. Liposarcoma / pathology. Neoplasms, Multiple Primary / pathology. Retroperitoneal Neoplasms / pathology. Uterine Neoplasms / pathology
  • [MeSH-minor] Adult. Comparative Genomic Hybridization. Female. Humans. Immunohistochemistry


61. Exacoustos C, Romanini ME, Amadio A, Amoroso C, Szabolcs B, Zupi E, Arduini D: Can gray-scale and color Doppler sonography differentiate between uterine leiomyosarcoma and leiomyoma? J Clin Ultrasound; 2007 Oct;35(8):449-57
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Can gray-scale and color Doppler sonography differentiate between uterine leiomyosarcoma and leiomyoma?
  • PURPOSE: To evaluate the role of gray-scale and color Doppler sonography to distinguish uterine leiomyosarcoma (LMS) from leiomyoma (LM).
  • [MeSH-major] Leiomyoma / ultrasonography. Leiomyosarcoma / ultrasonography. Ultrasonography, Doppler, Color / methods. Uterine Neoplasms / ultrasonography
  • [MeSH-minor] Adolescent. Adult. Aged. Child. Diagnosis, Differential. Female. Humans. Middle Aged. Retrospective Studies. Sensitivity and Specificity


62. Salas S, Stoeckle E, Collin F, Bui B, Terrier P, Guillou L, Trassard M, Ranchere-Vince D, Gregoire F, Coindre JM: Superficial soft tissue sarcomas (S-STS): a study of 367 patients from the French Sarcoma Group (FSG) database. Eur J Cancer; 2009 Aug;45(12):2091-102
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Superficial soft tissue sarcomas (S-STS): a study of 367 patients from the French Sarcoma Group (FSG) database.
  • We describe the clinical characteristics of a large series of S-STS (N=367) from the French Sarcoma Group (GSF-GETO) database and analyse the prognostic factors affecting outcome.
  • The most frequent tumour types were unclassified sarcoma (24.3%) and leiomyosarcoma (22.3%).
  • [MeSH-major] Neoplasm Recurrence, Local / pathology. Sarcoma / pathology. Soft Tissue Neoplasms / pathology
  • [MeSH-minor] Adolescent. Adult. Aged. Analysis of Variance. Female. France / epidemiology. Humans. Immunohistochemistry. Male. Middle Aged. Neoplasm Staging. Prognosis. Young Adult

  • Genetic Alliance. consumer health - Soft tissue sarcoma.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19351580.001).
  • [ISSN] 1879-0852
  • [Journal-full-title] European journal of cancer (Oxford, England : 1990)
  • [ISO-abbreviation] Eur. J. Cancer
  • [Language] eng
  • [Publication-type] Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  •  go-up   go-down


63. Ghaemmaghami F, Karimi Zarchi M, Hamedi B: High levels of CA125 (over 1,000 IU/ml) in patients with gynecologic disease and no malignant conditions: three cases and literature review. Arch Gynecol Obstet; 2007 Nov;276(5):559-61
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: Three patients were scheduled for laparatomy as ovarian cancer and leiomyosarcoma.
  • [MeSH-minor] Adult. Diagnosis, Differential. Female. Humans. Middle Aged. Ovarian Neoplasms / diagnosis

  • MedlinePlus Health Information. consumer health - Endometriosis.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Fibroids.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17497163.001).
  • [ISSN] 0932-0067
  • [Journal-full-title] Archives of gynecology and obstetrics
  • [ISO-abbreviation] Arch. Gynecol. Obstet.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / CA-125 Antigen
  • [Number-of-references] 13
  •  go-up   go-down


64. Fukunishi H, Funaki K, Ikuma K, Kaji Y, Sugimura K, Kitazawa R, Kitazawa S: Unsuspected uterine leiomyosarcoma: magnetic resonance imaging findings before and after focused ultrasound surgery. Int J Gynecol Cancer; 2007 May-Jun;17(3):724-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Unsuspected uterine leiomyosarcoma: magnetic resonance imaging findings before and after focused ultrasound surgery.
  • Uterine leiomyosarcoma, initially diagnosed as leiomyoma on magnetic resonance (MR) images, was disclosed after focused ultrasound surgery (FUS).
  • After laparoscopic myomectomy, this tumor was diagnosed as uterine leiomyosarcoma coexistent with leiomyoma.
  • The early stages of uterine leiomyosarcoma are clinically difficult to diagnose; therefore, both careful monitoring during FUS and close follow-up after the procedure are vital.
  • [MeSH-major] Leiomyosarcoma / diagnosis. Leiomyosarcoma / therapy. Magnetic Resonance Imaging. Ultrasonic Therapy. Uterine Neoplasms / diagnosis. Uterine Neoplasms / therapy
  • [MeSH-minor] Adult. Female. Humans. Laparoscopy

  • Genetic Alliance. consumer health - Leiomyosarcoma.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17300682.001).
  • [ISSN] 1048-891X
  • [Journal-full-title] International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
  • [ISO-abbreviation] Int. J. Gynecol. Cancer
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


65. Hansel DE, Herawi M, Montgomery E, Epstein JI: Spindle cell lesions of the adult prostate. Mod Pathol; 2007 Jan;20(1):148-58
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Spindle cell lesions of the adult prostate.
  • A subset of these lesions arises only within the prostate and generally represents entities that originate from the prostate epithelium or stroma, such as sclerosing adenosis, sarcomatoid carcinoma, stromal tumors of uncertain malignant potential (STUMP), and stromal sarcoma.
  • Another subset of spindle cell tumors that involve the prostate are also found at other sites and include solitary fibrous tumor, leiomyosarcoma, and neural lesions among others.
  • This review addresses the various entities that may present as spindle cell tumors within the adult prostate and discusses the functional aspects of the differential diagnosis of these lesions.
  • [MeSH-major] Prostate / pathology. Prostatic Neoplasms / pathology. Sarcoma / pathology
  • [MeSH-minor] Adult. Carcinosarcoma / pathology. Diagnosis, Differential. Gastrointestinal Stromal Tumors / pathology. Humans. Leiomyoma / pathology. Leiomyosarcoma / pathology. Male. Neoplasms, Muscle Tissue / pathology. Prostatic Hyperplasia / pathology. Rhabdomyosarcoma / pathology. Sclerosis

  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17170745.001).
  • [ISSN] 0893-3952
  • [Journal-full-title] Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
  • [ISO-abbreviation] Mod. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 48
  •  go-up   go-down


66. Mizushina Y, Bando M, Hosono T, Ohno S, Sohara Y, Hironaka M, Yukihiko S: [Case of pneumothorax due to pulmonary metastases from uterine leiomyosarcoma]. Nihon Kokyuki Gakkai Zasshi; 2008 May;46(5):379-84
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Case of pneumothorax due to pulmonary metastases from uterine leiomyosarcoma].
  • A 44-year-old woman who had undergone hystero-oophorectomy for uterine sarcoma presented to our hospital with palindromic pneumothorax and her chest CT revealed multiple cystic lesions.
  • After admission video-assisted thoracoscopic surgery (VATS) showed the pulmonary lesions to be primarily leiomyoma, however, further examination revealed that her uterine sarcoma resected in 2000 exhibited not only mitosis but also venous invasion.
  • We therefore considered her lung tumors as metastases from uterine leiomyosarcoma.
  • [MeSH-major] Leiomyosarcoma / secondary. Lung Neoplasms / secondary. Pneumothorax / etiology. Uterine Neoplasms / pathology
  • [MeSH-minor] Adult. Biomarkers, Tumor / analysis. Diagnosis, Differential. Female. Humans. Pneumonectomy. Thoracic Surgery, Video-Assisted. Tomography, X-Ray Computed


67. Vossen JA, Kamel IR, Buijs M, Liapi E, Georgiades CS, Hong K, Geschwind JF: Role of functional magnetic resonance imaging in assessing metastatic leiomyosarcoma response to chemoembolization. J Comput Assist Tomogr; 2008 May-Jun;32(3):347-52
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Role of functional magnetic resonance imaging in assessing metastatic leiomyosarcoma response to chemoembolization.
  • PURPOSE: To assess the value of functional magnetic resonance (MR) imaging in the evaluation of early tumor response after transarterial chemoembolization (TACE) for metastatic leiomyosarcoma and compare tumor response using functional MR imaging versus traditional imaging response assessment, which is based on tumor size.
  • MATERIALS AND METHODS: We evaluated 31 lesions in 10 patients with liver metastases from leiomyosarcoma using MR imaging studies before and after TACE.
  • CONCLUSION: In patients with leiomyosarcoma and liver metastases who were treated with TACE, significant early changes in the treated lesions occurred on functional MR imaging.
  • [MeSH-major] Chemoembolization, Therapeutic. Leiomyosarcoma / diagnosis. Leiomyosarcoma / therapy. Magnetic Resonance Imaging. Soft Tissue Neoplasms / diagnosis. Soft Tissue Neoplasms / therapy
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Female. Follow-Up Studies. Humans. Liver Neoplasms / secondary. Male. Middle Aged. Neoplasm Metastasis. Tomography, X-Ray Computed. Treatment Outcome

  • Genetic Alliance. consumer health - Leiomyosarcoma.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18520535.001).
  • [ISSN] 0363-8715
  • [Journal-full-title] Journal of computer assisted tomography
  • [ISO-abbreviation] J Comput Assist Tomogr
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


68. Suárez Antelo J, Rodríguez García C, Montero Martínez C, Verea Hernando H: [Pulmonary Ewing sarcoma/primitive neuroectodermal tumor: a case report and a review of the literature]. Arch Bronconeumol; 2010 Jan;46(1):44-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Pulmonary Ewing sarcoma/primitive neuroectodermal tumor: a case report and a review of the literature].
  • [Transliterated title] Sarcoma de Ewing pulmonar/tumor neuroectodérmico primitivo (PNET): aportación de un caso y revisión de la bibliografía.
  • The most common intrathoracic variants are synovial sarcoma, angiosarcoma, leiomyosarcoma, rhabdomyosarcoma, and sarcomatoid mesothelioma.
  • Although thoracic Ewing sarcoma/primitive neuroectodermal tumor (PNET) usually develops on the chest wall, there have been reports of primary Ewing sarcoma/PNET of the lung.
  • We present the case of a 22-year-old woman with Ewing sarcoma/PNET diagnosed following histologic, immunohistochemical, and in situ hybridization studies of a bronchial biopsy specimen.
  • [MeSH-major] Lung Neoplasms. Neuroectodermal Tumors, Primitive. Sarcoma, Ewing
  • [MeSH-minor] Female. Humans. Young Adult

  • Genetic Alliance. consumer health - Ewing's Sarcoma.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2009 SEPAR. Published by Elsevier Espana. All rights reserved.
  • (PMID = 19656607.001).
  • [ISSN] 1579-2129
  • [Journal-full-title] Archivos de bronconeumología
  • [ISO-abbreviation] Arch. Bronconeumol.
  • [Language] spa
  • [Publication-type] Case Reports; English Abstract; Journal Article; Review
  • [Publication-country] Spain
  • [Number-of-references] 13
  •  go-up   go-down


69. Pan Q, Luo X, Chegini N: Differential expression of microRNAs in myometrium and leiomyomas and regulation by ovarian steroids. J Cell Mol Med; 2008 Jan-Feb;12(1):227-40
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Given the emerging roles of microRNAs (miRNAs) as key regulator of mRNA stability we assessed their expression profile in paired myometrium and leiomyoma, their isolated smooth muscle cells (MSMC and LSMC), a spontaneously transformed leiomyoma smooth muscle cells (T-LSMC) and SK-LMS-1, a leiomyosarcoma cell line using microarray and real time PCR.
  • [MeSH-minor] Adult. Antineoplastic Agents, Hormonal / pharmacology. Estradiol / analogs & derivatives. Estradiol / pharmacology. Estrogens / pharmacology. Female. Gene Expression Profiling. Gene Expression Regulation, Neoplastic. Hormone Antagonists / pharmacology. Humans. Medroxyprogesterone Acetate / pharmacology. Mifepristone / pharmacology. Myocytes, Smooth Muscle / drug effects. Myocytes, Smooth Muscle / metabolism. Oligonucleotide Array Sequence Analysis. RNA, Messenger / genetics. RNA, Messenger / metabolism. Reverse Transcriptase Polymerase Chain Reaction

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Fibroids.
  • Hazardous Substances Data Bank. FULVESTRANT .
  • Hazardous Substances Data Bank. ESTRADIOL .
  • Hazardous Substances Data Bank. MIFEPRISTONE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Hum Reprod. 2002 Dec;17(12):3213-9 [12456626.001]
  • [Cites] Reprod Biol Endocrinol. 2007;5:34 [17716379.001]
  • [Cites] J Soc Gynecol Investig. 2003 Apr;10(3):161-71 [12699880.001]
  • [Cites] Fertil Steril. 2003 Aug;80(2):266-76 [12909484.001]
  • [Cites] Mol Cancer Res. 2003 Oct;1(12):882-91 [14573789.001]
  • [Cites] Steroids. 2003 Nov;68(10-13):1019-32 [14667995.001]
  • [Cites] Science. 2004 Jan 2;303(5654):83-6 [14657504.001]
  • [Cites] Cell. 2004 Jan 23;116(2):281-97 [14744438.001]
  • [Cites] Genes Chromosomes Cancer. 2004 Jun;40(2):97-108 [15101043.001]
  • [Cites] Obstet Gynecol. 2004 Jun;103(6):1331-6 [15172874.001]
  • [Cites] Nature. 2004 Sep 16;431(7006):350-5 [15372042.001]
  • [Cites] Endocrinology. 2005 Mar;146(3):1074-96 [15604208.001]
  • [Cites] Endocrinology. 2005 Mar;146(3):1097-118 [15604209.001]
  • [Cites] Obstet Gynecol. 2005 Mar;105(3):563-8 [15738025.001]
  • [Cites] Cancer Res. 2005 Jul 15;65(14):6029-33 [16024602.001]
  • [Cites] RNA. 2005 Dec;11(12):1753-61 [16314451.001]
  • [Cites] J Soc Gynecol Investig. 2006 Feb;13(2):136-44 [16443508.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2257-61 [16461460.001]
  • [Cites] Nat Cell Biol. 2006 Mar;8(3):278-84 [16489342.001]
  • [Cites] Mol Hum Reprod. 2002 Dec;8(12):1071-8 [12468639.001]
  • [Cites] Fertil Steril. 2000 Jun;73(6):1219-25 [10856486.001]
  • [Cites] Hum Reprod Update. 2001 Jan-Feb;7(1):8-14 [11212080.001]
  • [Cites] Fertil Steril. 2001 Jun;75(6):1198-205 [11384649.001]
  • [Cites] Aust N Z J Obstet Gynaecol. 2001 Aug;41(3):295-302 [11592544.001]
  • [Cites] Fertil Steril. 2002 Jul;78(1):114-21 [12095500.001]
  • [Cites] Bioinformatics. 2002;18 Suppl 1:S96-104 [12169536.001]
  • [Cites] Fertil Steril. 2006 Feb;85(2):462-7 [16595228.001]
  • [Cites] Mol Hum Reprod. 2006 Mar;12(3):187-207 [16524927.001]
  • [Cites] Gastroenterology. 2006 Jun;130(7):2113-29 [16762633.001]
  • [Cites] Cancer Res. 2006 Jun 15;66(12):6097-104 [16778182.001]
  • [Cites] Methods Enzymol. 2006;411:14-34 [16939783.001]
  • [Cites] Biochem Biophys Res Commun. 2006 Oct 13;349(1):59-68 [16934749.001]
  • [Cites] J Clin Oncol. 2006 Oct 10;24(29):4677-84 [16966691.001]
  • [Cites] Oncogene. 2006 Oct 9;25(46):6156-62 [17028594.001]
  • [Cites] Oncogene. 2006 Oct 9;25(46):6163-9 [17028595.001]
  • [Cites] Oncogene. 2006 Oct 9;25(46):6176-87 [17028597.001]
  • [Cites] Oncogene. 2006 Oct 9;25(46):6202-10 [17028600.001]
  • [Cites] Steroids. 2006 Nov;71(11-12):960-5 [16935316.001]
  • [Cites] Nat Rev Cancer. 2006 Nov;6(11):857-66 [17060945.001]
  • [Cites] Childs Nerv Syst. 2006 Nov;22(11):1419-25 [16983573.001]
  • [Cites] Trends Mol Med. 2006 Dec;12(12):580-7 [17071139.001]
  • [Cites] J Biol Chem. 2007 Jan 26;282(4):2135-43 [17135249.001]
  • [Cites] J Biol Chem. 2007 Jan 26;282(4):2130-4 [17135268.001]
  • [Cites] Genes Chromosomes Cancer. 2007 Apr;46(4):336-47 [17243163.001]
  • [Cites] Mol Endocrinol. 2007 May;21(5):1132-47 [17312270.001]
  • [Cites] Oncogene. 2007 Apr 26;26(19):2799-803 [17072344.001]
  • [Cites] Oncogene. 2007 Jun 28;26(30):4442-52 [17237814.001]
  • [RetractionIn] J Cell Mol Med. 2015 Oct;19(10):2512 [26411639.001]
  • [CommentIn] Fed Regist. 2017 Aug 3;82(148):36150-36151 [28857091.001]
  • (PMID = 18182067.001).
  • [ISSN] 1582-1838
  • [Journal-full-title] Journal of cellular and molecular medicine
  • [ISO-abbreviation] J. Cell. Mol. Med.
  • [Language] eng
  • [Grant] United States / NICHD NIH HHS / HD / R01 HD037432; United States / NICHD NIH HHS / HD / R01 HD037432-07; United States / NICHD NIH HHS / HD / HD37432
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Retracted Publication
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antineoplastic Agents, Hormonal; 0 / Estrogens; 0 / Hormone Antagonists; 0 / MicroRNAs; 0 / RNA, Messenger; 0 / Steroids; 22X328QOC4 / fulvestrant; 320T6RNW1F / Mifepristone; 4TI98Z838E / Estradiol; C2QI4IOI2G / Medroxyprogesterone Acetate
  • [Other-IDs] NLM/ NIHMS121248; NLM/ PMC2730932
  •  go-up   go-down


70. Liu JP, Cui QC: [Laryngeal pleomorphic rhabdomyosarcoma: report of a case]. Zhonghua Bing Li Xue Za Zhi; 2007 Aug;36(8):573-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-minor] Adult. Diagnosis, Differential. Histiocytoma, Malignant Fibrous / pathology. Humans. Laryngectomy. Leiomyosarcoma / pathology. Male. Tomography, X-Ray Computed. Vimentin / metabolism

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17980114.001).
  • [ISSN] 0529-5807
  • [Journal-full-title] Zhonghua bing li xue za zhi = Chinese journal of pathology
  • [ISO-abbreviation] Zhonghua Bing Li Xue Za Zhi
  • [Language] chi
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Vimentin
  •  go-up   go-down


71. Nur S, Rosenblum WD, Katta UD, Islam H, Brown K, Ramaswamy G: Epstein-Barr virus-associated multifocal leiomyosarcomas arising in a cardiac transplant recipient: autopsy case report and review of the literature. J Heart Lung Transplant; 2007 Sep;26(9):944-52
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Epstein-Barr Virus Infections / complications. Heart Transplantation. Herpesvirus 4, Human. Immunosuppression / adverse effects. Leiomyosarcoma / virology. Neoplasms, Multiple Primary / virology
  • [MeSH-minor] Adult. Humans. Male. Smooth Muscle Tumor / immunology. Smooth Muscle Tumor / pathology. Smooth Muscle Tumor / virology

  • MedlinePlus Health Information. consumer health - Heart Transplantation.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17845934.001).
  • [ISSN] 1557-3117
  • [Journal-full-title] The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
  • [ISO-abbreviation] J. Heart Lung Transplant.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 22
  •  go-up   go-down


72. Reed NS, Mangioni C, Malmström H, Scarfone G, Poveda A, Pecorelli S, Tateo S, Franchi M, Jobsen JJ, Coens C, Teodorovic I, Vergote I, Vermorken JB, European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group: Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874). Eur J Cancer; 2008 Apr;44(6):808-18
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • All uterine sarcoma subtypes were permitted.
  • [MeSH-major] Carcinosarcoma / radiotherapy. Leiomyosarcoma / radiotherapy. Sarcoma, Endometrial Stromal / radiotherapy. Uterine Neoplasms / radiotherapy
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Disease Progression. Disease-Free Survival. Female. Humans. Middle Aged. Neoplasm Recurrence, Local / prevention & control. Radiotherapy / adverse effects. Radiotherapy, Adjuvant / methods. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • Faculty of 1000. commentaries/discussion - See the articles recommended by F1000Prime's Faculty of more than 8,000 leading experts in Biology and Medicine. (subscription/membership/fee required).
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [ErratumIn] Eur J Cancer. 2008 Jul;44(11):1612
  • (PMID = 18378136.001).
  • [ISSN] 0959-8049
  • [Journal-full-title] European journal of cancer (Oxford, England : 1990)
  • [ISO-abbreviation] Eur. J. Cancer
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / 3U10 CA11488-18S1; United States / NCI NIH HHS / CA / 5U10 CA011488-38
  • [Publication-type] Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Investigator] Mangioni C; Malmstrom H; Scarfone G; Poveda A; Tateo S; Pecorelli S; Favalli G; Franchi M; Jobsen J; van Bunningen B; Splinter T; van der Burg ME; Vergote I; Drouin P; Zola P; Frankendaal B; Schepansky A; Swenerton K; Stuart G; Scarabelli C; Mangili G; van Rijswijk R; van Putten; Chevalier B; Stoot JE; Beex L; Souhami L; Heintz AP; Bonnefoi H; Koelbl H; Kobierska A; Guthrie D; Maggino T; di Palumbo VS; Bessette P; van Wijk A; Verheijen R
  •  go-up   go-down


73. Hensley ML, Ishill N, Soslow R, Larkin J, Abu-Rustum N, Sabbatini P, Konner J, Tew W, Spriggs D, Aghajanian CA: Adjuvant gemcitabine plus docetaxel for completely resected stages I-IV high grade uterine leiomyosarcoma: Results of a prospective study. Gynecol Oncol; 2009 Mar;112(3):563-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adjuvant gemcitabine plus docetaxel for completely resected stages I-IV high grade uterine leiomyosarcoma: Results of a prospective study.
  • OBJECTIVE: Patients with completely resected stages I-IV high grade uterine leiomyosarcoma are at high risk for recurrence.
  • We sought to determine whether adjuvant gemcitabine-docetaxel would yield a 2-year progression-free survival of at least 50% in this leiomyosarcoma population.
  • Among the 18 patients with stages I or II uterine leiomyosarcoma, 59% remain progression-free at 2 years, with a median progression-free survival of 39 months.
  • CONCLUSIONS: Post-resection gemcitabine-docetaxel for stages I-IV high-grade uterine leiomyosarcoma yields 2-year progression-free survival rates that appear superior to historical rates.
  • Gemcitabine-docetaxel merits further study as part of an adjuvant strategy for patients with completely resected, early-stage uterine leiomyosarcoma.
  • [MeSH-major] Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Leiomyosarcoma / drug therapy. Uterine Neoplasms / drug therapy
  • [MeSH-minor] Adult. Aged. Chemotherapy, Adjuvant. Deoxycytidine / administration & dosage. Deoxycytidine / analogs & derivatives. Disease-Free Survival. Female. Humans. Middle Aged. Neoplasm Staging. Prospective Studies. Taxoids / administration & dosage

  • Genetic Alliance. consumer health - Leiomyosarcoma.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. DOCETAXEL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19135708.001).
  • [ISSN] 1095-6859
  • [Journal-full-title] Gynecologic oncology
  • [ISO-abbreviation] Gynecol. Oncol.
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Taxoids; 0W860991D6 / Deoxycytidine; 15H5577CQD / docetaxel; B76N6SBZ8R / gemcitabine
  •  go-up   go-down


74. Simsir A, Carter W, Elgert P, Cangiarella J: Reporting endometrial cells in women 40 years and older: assessing the clinical usefulness of Bethesda 2001. Am J Clin Pathol; 2005 Apr;123(4):571-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • There was tissue follow-up for 130 postmenopausal women: 10 (7.7%) had significant findings (endometrial adenocarcinoma, 6 [2 (33%) in asymptomatic women]; complex atypical endometrial hyperplasia [CAH], 3; leiomyosarcoma, 1); 20 were receiving hormone replacement therapy (HRT; n = 15) or tamoxifen (n = 5); 2 (10%) had significant pathology (endometrial adenocarcinoma, 1; CAH, 1).
  • Eight not taking hormones (7.3%) had significant pathology (adenocarcinoma, 5; CAH, 2; leiomyosarcoma, 1).
  • [MeSH-minor] Adult. Female. Hormone Replacement Therapy. Humans. Middle Aged. Vaginal Smears

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15743742.001).
  • [ISSN] 0002-9173
  • [Journal-full-title] American journal of clinical pathology
  • [ISO-abbreviation] Am. J. Clin. Pathol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


75. Kasper B, Dietrich S, Mechtersheimer G, Ho AD, Egerer G: Large institutional experience with dose-intensive chemotherapy and stem cell support in the management of sarcoma patients. Oncology; 2007;73(1-2):58-64
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Large institutional experience with dose-intensive chemotherapy and stem cell support in the management of sarcoma patients.
  • BACKGROUND: The prognosis of patients with advanced sarcoma remains poor.
  • METHODS: We present a large institutional experience of sarcoma patients treated with this therapy option.
  • [MeSH-major] Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Sarcoma / drug therapy. Sarcoma / surgery. Stem Cell Transplantation
  • [MeSH-minor] Adult. Aged. Chondrosarcoma / drug therapy. Chondrosarcoma / surgery. Disease-Free Survival. Drug Administration Schedule. Female. Humans. Leiomyosarcoma / drug therapy. Leiomyosarcoma / surgery. Liposarcoma / drug therapy. Liposarcoma / surgery. Male. Middle Aged. Osteosarcoma / drug therapy. Osteosarcoma / surgery. Retrospective Studies. Rhabdomyosarcoma / drug therapy. Rhabdomyosarcoma / surgery. Sarcoma, Ewing / drug therapy. Sarcoma, Ewing / surgery. Sarcoma, Synovial / drug therapy. Sarcoma, Synovial / surgery

  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] : (c) 2008 S. Karger AG, Basel
  • (PMID = 18334832.001).
  • [ISSN] 1423-0232
  • [Journal-full-title] Oncology
  • [ISO-abbreviation] Oncology
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Switzerland
  •  go-up   go-down


76. Caso J, Seigne J, Back M, Spiess PE, Pow-Sang J, Sexton WJ: Circumferential resection of the inferior vena cava for primary and recurrent malignant tumors. J Urol; 2009 Sep;182(3):887-93
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Primary tumor type was renal cell carcinoma in 7 patients, metastatic testicular cancer in 5, leiomyosarcoma in 3, and adrenal cortical carcinoma, primary retroperitoneal germ cell tumor and upper tract transitional cell carcinoma in 1 each.
  • [MeSH-minor] Adult. Aged. Blood Vessel Prosthesis Implantation. Female. Humans. Male. Middle Aged. Vascular Surgical Procedures / adverse effects. Vascular Surgical Procedures / methods. Young Adult

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19616230.001).
  • [ISSN] 1527-3792
  • [Journal-full-title] The Journal of urology
  • [ISO-abbreviation] J. Urol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


77. Shah H, Pervez S: Immunophenotypic characterization of high grade pleomorphic sarcomas: a demographic and immunohistochemical study in a major referral center of Pakistan. J Pak Med Assoc; 2005 Mar;55(3):101-4
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: Of the 134 cases which were characterized, 38.1% were pleomorphic leiomyosarcoma, followed by pleomorphic rhabdomyosarcoma 14.9%, Malignant Peripheral Nerve Sheath Tumour 9%, pleomorphic liposarcoma 3.7% and pleomorphic storiform Malignant Fibrous Histiocytoma 0.7%.
  • Mean/ median age for Leiomyosarcoma was 50/50, for Rhabdomyosarcomas 33/22, for MPNST 42/41, for Liposarcoma 52/50 and for Malignant Fibrous Histiocytoma 46/46 respectively.
  • The commonest site for leiomyosarcoma was lower limb (43%), for rhabdomyosarcoma head and neck (42%), for MPNSTthorax (36.4%) and for liposarcoma abdomen (50%).
  • CONCLUSION: It was concluded that the most common pleomorphic sarcoma occurring in our adult population was Leiomyosarcoma, and that immunohistochemical stains are essential in most cases for further characterization of pleomorphic high grade sarcoma.
  • [MeSH-major] Sarcoma / pathology. Soft Tissue Neoplasms / pathology
  • [MeSH-minor] Adult. Age Distribution. Aged. Antigens, Neoplasm / immunology. Biomarkers, Tumor / analysis. Cross-Sectional Studies. Humans. Immunoenzyme Techniques. Immunohistochemistry. Leiomyosarcoma / pathology. Liposarcoma / genetics. Liposarcoma / pathology. Middle Aged. Nerve Sheath Neoplasms / genetics. Nerve Sheath Neoplasms / pathology. Pakistan. Phenotype. Rhabdomyosarcoma / genetics. Rhabdomyosarcoma / pathology. Surveys and Questionnaires

  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15852744.001).
  • [ISSN] 0030-9982
  • [Journal-full-title] JPMA. The Journal of the Pakistan Medical Association
  • [ISO-abbreviation] J Pak Med Assoc
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Pakistan
  • [Chemical-registry-number] 0 / Antigens, Neoplasm; 0 / Biomarkers, Tumor
  •  go-up   go-down


78. Sunde J, Chetty-John S, Shlobin OA, Boice CR: Epstein-Barr virus-associated uterine leiomyosarcoma in an adult lung transplant patient. Obstet Gynecol; 2010 Feb;115(2 Pt 2):434-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Epstein-Barr virus-associated uterine leiomyosarcoma in an adult lung transplant patient.
  • She presented 5 months later with an EBV-positive uterine leiomyosarcoma.
  • CONCLUSION: Epstein-Barr virus-associated leiomyosarcoma can occur in the uterus in immunosuppressed patients.
  • [MeSH-major] Herpesvirus 4, Human / isolation & purification. Immunocompromised Host. Leiomyosarcoma / virology. Lung Transplantation / immunology. Neoplasm Recurrence, Local / virology. Uterine Neoplasms / virology
  • [MeSH-minor] Adult. Fatal Outcome. Female. Humans


79. Nappi L, Di Spiezio Sardo A, Indraccolo U, Bettocchi S: Hysteroscopic resection of uterine leiomyosarcoma: a case report and literature review. J Minim Invasive Gynecol; 2008 May-Jun;15(3):380-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Hysteroscopic resection of uterine leiomyosarcoma: a case report and literature review.
  • This case reports the hysteroscopic resection of an unsuspected leiomyosarcoma of the uterus in a 41-year-old multiparous woman with recurrent episodes of abnormal uterine bleeding.
  • [MeSH-major] Antineoplastic Combined Chemotherapy Protocols. Diagnostic Errors. Hysteroscopy / methods. Leiomyoma / diagnosis. Leiomyosarcoma / diagnosis. Uterine Neoplasms / diagnosis
  • [MeSH-minor] Adult. Chemotherapy, Adjuvant. Combined Modality Therapy. Doxorubicin / administration & dosage. Female. Humans. Hysterectomy. Ifosfamide / administration & dosage. Lymphatic Metastasis. Mesna / administration & dosage

  • Genetic Alliance. consumer health - Leiomyosarcoma.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Fibroids.
  • Hazardous Substances Data Bank. DOXORUBICIN .
  • Hazardous Substances Data Bank. IFOSFAMIDE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18439518.001).
  • [ISSN] 1553-4650
  • [Journal-full-title] Journal of minimally invasive gynecology
  • [ISO-abbreviation] J Minim Invasive Gynecol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 80168379AG / Doxorubicin; NR7O1405Q9 / Mesna; UM20QQM95Y / Ifosfamide
  • [Number-of-references] 41
  •  go-up   go-down


80. Tilkorn DJ, Hauser J, Ring A, Goertz O, Stricker I, Steinau HU, Kuhnen C: Leiomyosarcoma of intravascular origin--a rare tumor entity: clinical pathological study of twelve cases. World J Surg Oncol; 2010;8:103
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Leiomyosarcoma of intravascular origin--a rare tumor entity: clinical pathological study of twelve cases.
  • METHOD: During 2000 and 2009 twelve patients were identified with an intravascular origin of a leiomyosarcoma.
  • RESULTS: Vascular leiomyosarcomas accounted for 0.7% of all malignant soft tissue tumors treated at our soft tissue sarcoma reference center.
  • [MeSH-major] Leiomyosarcoma / pathology. Neoplasm Recurrence, Local / pathology. Vascular Neoplasms / pathology. Vena Cava, Inferior / pathology
  • [MeSH-minor] Adult. Aged. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Combined Modality Therapy. Diagnosis, Differential. Female. Humans. Male. Middle Aged. Prospective Studies. Radiotherapy Dosage. Survival Rate. Treatment Outcome

  • Genetic Alliance. consumer health - Leiomyosarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Pathologe. 1996 May;17(3):231-4 [8710797.001]
  • [Cites] Virchows Arch. 1999 Nov;435(5):473-8 [10592050.001]
  • [Cites] Virchows Arch. 2007 Feb;450(2):235-7 [17109153.001]
  • [Cites] Cancer. 2007 Jan 15;109(2):282-91 [17154171.001]
  • [Cites] Clin Oncol (R Coll Radiol). 2005 May;17(3):201 [15901009.001]
  • [Cites] Ann Surg. 1958 Nov;148(5):859-61 [13595550.001]
  • [Cites] Cancer. 1999 Mar 1;85(5):1077-83 [10091791.001]
  • [Cites] Ann Thorac Surg. 1998 Oct;66(4):1405 [9800844.001]
  • [Cites] Virchows Arch. 1998 Jul;433(1):97-100 [9692833.001]
  • [Cites] Pathologe. 1998 May;19(3):176-86 [9648142.001]
  • [Cites] J Cardiovasc Surg (Torino). 1997 Feb;38(1):33-5 [9128119.001]
  • [Cites] World J Surg Oncol. 2008;6:113 [18954426.001]
  • [Cites] J Radiol. 2000 Jun;81(6):632-5 [10844341.001]
  • [Cites] Eur J Radiol. 1995 May;20(1):23-7 [7556247.001]
  • [Cites] J Vasc Surg. 1992 Apr;15(4):595-603 [1560548.001]
  • [Cites] Cancer. 1987 Sep 15;60(6):1238-42 [3304612.001]
  • [Cites] Cancer. 1986 Apr 1;57(7):1395-400 [3081244.001]
  • [Cites] Gynecol Oncol. 1986 Jan;23(1):59-64 [3943753.001]
  • [Cites] Cancer. 1984 Nov 15;54(10):2147-59 [6488138.001]
  • [Cites] Cancer. 1979 Nov;44(5):1684-91 [498039.001]
  • [Cites] Surgery. 1973 Mar;73(3):390-400 [4687797.001]
  • [Cites] Am J Surg Pathol. 2002 Jan;26(1):14-24 [11756765.001]
  • (PMID = 21092216.001).
  • [ISSN] 1477-7819
  • [Journal-full-title] World journal of surgical oncology
  • [ISO-abbreviation] World J Surg Oncol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC3012034
  •  go-up   go-down


81. Podboj J, Smid L: Endoscopic surgery with curative intent for malignant tumors of the nose and paranasal sinuses. Eur J Surg Oncol; 2007 Nov;33(9):1081-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The lesions included 11 carcinomas, two malignant melanomas, one olfactory neuroblastoma, one hondrosarcoma and one leiomyosarcoma.
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Carcinoma / pathology. Carcinoma / surgery. Chondrosarcoma / pathology. Chondrosarcoma / surgery. Esthesioneuroblastoma, Olfactory / pathology. Esthesioneuroblastoma, Olfactory / surgery. Follow-Up Studies. Humans. Leiomyosarcoma / pathology. Leiomyosarcoma / surgery. Melanoma / pathology. Melanoma / surgery. Middle Aged. Neoplasm Staging

  • MedlinePlus Health Information. consumer health - Endoscopy.
  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17329065.001).
  • [ISSN] 1532-2157
  • [Journal-full-title] European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
  • [ISO-abbreviation] Eur J Surg Oncol
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article
  • [Publication-country] England
  •  go-up   go-down


82. Hayashi T, Tagawa T, Ashizawa K, Abe K, Kinoshita N, Tsutsui S, Anami M, Nagayasu T: Contrast-enhanced dynamic magnetic resonance imaging of primary pulmonary leiomyosarcoma. Tohoku J Exp Med; 2006 Nov;210(3):263-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Contrast-enhanced dynamic magnetic resonance imaging of primary pulmonary leiomyosarcoma.
  • The lesion was accordingly diagnosed as leiomyosarcoma with low grade malignancy, and right lower lobectomy was performed.
  • [MeSH-major] Contrast Media / pharmacology. Leiomyosarcoma / diagnosis. Leiomyosarcoma / pathology. Lung Neoplasms / diagnosis. Lung Neoplasms / pathology. Magnetic Resonance Imaging / methods
  • [MeSH-minor] Adult. Humans. Immunohistochemistry. Lung / pathology. Male. Radiography, Thoracic / methods. Thoracic Surgery, Video-Assisted. Tomography, X-Ray Computed / methods

  • Genetic Alliance. consumer health - Leiomyosarcoma.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17077604.001).
  • [ISSN] 0040-8727
  • [Journal-full-title] The Tohoku journal of experimental medicine
  • [ISO-abbreviation] Tohoku J. Exp. Med.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Contrast Media
  •  go-up   go-down


83. Kawaguchi K, Oda Y, Saito T, Takahira T, Yamamoto H, Tamiya S, Iwamoto Y, Tsuneyoshi M: Genetic and epigenetic alterations of the PTEN gene in soft tissue sarcomas. Hum Pathol; 2005 Apr;36(4):357-63
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • To investigate the potential role and the alteration of the PTEN gene in soft tissue sarcomas (STSs), we searched for homozygous deletion and promoter hypermethylation in a series of 48 STSs that was composed of malignant fibrous histiocytoma, leiomyosarcoma, malignant peripheral nerve sheath tumor, including 2 cases with a mutation that we previously reported; differential polymerase chain reaction and methylation-specific polymerase chain reaction, respectively, were used for the analyses.
  • [MeSH-major] Membrane Proteins / genetics. Phosphoric Monoester Hydrolases / genetics. Protein Tyrosine Phosphatases / genetics. Sarcoma / genetics. Soft Tissue Neoplasms / genetics
  • [MeSH-minor] Adolescent. Adult. Aged. Cell Proliferation. Child. Child, Preschool. DNA Methylation. Female. Gene Deletion. Humans. Infant. Male. Middle Aged. Mutation. PTEN Phosphohydrolase. Promoter Regions, Genetic

  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15891996.001).
  • [ISSN] 0046-8177
  • [Journal-full-title] Human pathology
  • [ISO-abbreviation] Hum. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Membrane Proteins; EC 3.1.3.- / Phosphoric Monoester Hydrolases; EC 3.1.3.48 / Protein Tyrosine Phosphatases; EC 3.1.3.48 / TPTE protein, human; EC 3.1.3.67 / PTEN Phosphohydrolase
  •  go-up   go-down


84. Yu RS, Chen Y, Jiang B, Wang LH, Xu XF: Primary hepatic sarcomas: CT findings. Eur Radiol; 2008 Oct;18(10):2196-205
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In this pictorial review, we summarized computed tomography (CT) findings of some relatively common types of hepatic sarcomas, including angiosarcoma, epithelioid hemangioendothelioma (EHE), liposarcoma, undifferentiated embryonal sarcoma (UES), leiomyosarcoma, malignant fibrous histiocytoma (MFH), and carcinosarcoma (including cystadenocarcinosarcoma).
  • [MeSH-major] Liver / diagnostic imaging. Liver Neoplasms / diagnostic imaging. Sarcoma / diagnostic imaging. Tomography, X-Ray Computed / methods
  • [MeSH-minor] Adult. Aged. Child. Female. Humans. Male. Middle Aged

  • MedlinePlus Health Information. consumer health - CT Scans.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Magn Reson Imaging. 2004 Jul;22(6):897-900 [15234460.001]
  • [Cites] Korean J Radiol. 2007 Jul-Aug;8(4):343-7 [17673846.001]
  • [Cites] Surg Today. 2002;32(5):446-9 [12061699.001]
  • [Cites] Korean J Radiol. 2007 Mar-Apr;8(2):180-3 [17420638.001]
  • [Cites] Arch Pathol Lab Med. 2001 Mar;125(3):410-2 [11231494.001]
  • [Cites] Radiographics. 2001 Jul-Aug;21(4):895-910 [11452064.001]
  • [Cites] Korean J Gastroenterol. 2006 Jan;47(1):5-14 [16434863.001]
  • [Cites] Radiology. 2006 Jul;240(1):295-8 [16793987.001]
  • [Cites] J Comput Assist Tomogr. 1997 Jan-Feb;21(1):100-2 [9022777.001]
  • [Cites] Cancer. 1999 Feb 1;85(3):562-82 [10091730.001]
  • [Cites] Hepatobiliary Pancreat Dis Int. 2006 Nov;5(4):620-3 [17085355.001]
  • [Cites] Radiographics. 1994 Jan;14 (1):153-66; quiz 167-8 [8128048.001]
  • [Cites] World J Gastroenterol. 2006 Feb 21;12(7):1157-9 [16534865.001]
  • [Cites] AJR Am J Roentgenol. 1998 Sep;171(3):900-1 [9725359.001]
  • [Cites] Clin Radiol. 1993 Nov;48(5):321-5 [8258223.001]
  • [Cites] AJR Am J Roentgenol. 1989 Jan;152(1):63-72 [2535770.001]
  • [Cites] AJR Am J Roentgenol. 1993 Dec;161(6):1331-2 [8249754.001]
  • [Cites] Magn Reson Imaging. 1993;11(1):139-43 [8380881.001]
  • [Cites] Hepatology. 2001 Mar;33(3):647-51 [11230745.001]
  • [Cites] Acta Radiol. 2007 Dec;48(10):1061-5 [18038349.001]
  • [Cites] Radiographics. 2005 Sep-Oct;25(5):1371-95 [16160117.001]
  • [Cites] Radiology. 1997 Jun;203(3):779-83 [9169704.001]
  • [Cites] Clin Imaging. 1996 Oct-Dec;20(4):273-5 [8959367.001]
  • [Cites] Cancer. 2007 Apr 1;109(7):1391-6 [17315167.001]
  • [Cites] Radiology. 1988 Oct;169(1):145-8 [3420251.001]
  • [Cites] AJR Am J Roentgenol. 2000 Jul;175(1):165-70 [10882268.001]
  • [Cites] Radiat Med. 2006 Jun;24(5):369-72 [16958416.001]
  • [Cites] Cancer. 1978 Jul;42(1):336-48 [208754.001]
  • [Cites] Chin Med J (Engl). 2004 Oct;117(10):1586-7 [15498391.001]
  • [Cites] Arch Pathol Lab Med. 1985 Sep;109(9):853-7 [3927870.001]
  • [Cites] Abdom Imaging. 1999 Jul-Aug;24(4):386-91 [10390563.001]
  • [Cites] AJR Am J Roentgenol. 1992 Jul;159(1):53-7 [1302463.001]
  • [Cites] Dig Dis Sci. 2003 Apr;48(4):677-82 [12741455.001]
  • [Cites] Gastrointest Radiol. 1992 Winter;17(1):58-62 [1544560.001]
  • [Cites] Eur Radiol. 2000;10(1):129-33 [10663729.001]
  • [Cites] Radiology. 2002 Mar;222(3):667-73 [11867783.001]
  • [Cites] Am J Surg Pathol. 2007 Jun;31(6):817-26 [17527068.001]
  • [Cites] Cancer Imaging. 2005 Aug 23;5:89-94 [16154826.001]
  • [Cites] Am J Gastroenterol. 1995 Apr;90(4):649-52 [7717329.001]
  • [Cites] World J Surg Oncol. 2006 Feb 20;4:9 [16504010.001]
  • [Cites] Radiology. 1989 Apr;171(1):63-8 [2648478.001]
  • [Cites] Mt Sinai J Med. 2005 Jan;72(1):50-2 [15682264.001]
  • [Cites] Cancer. 2002 Jan 1;94(1):252-7 [11815984.001]
  • [Cites] J Clin Ultrasound. 2001 Jan;29(1):44-7 [11180184.001]
  • [Cites] Pediatr Transplant. 2001 Oct;5(5):365-9 [11560757.001]
  • [Cites] Eur J Radiol. 1995 Mar;19(3):177-82 [7601167.001]
  • [Cites] Abdom Imaging. 1996 Mar-Apr;21(2):157-60 [8661764.001]
  • [Cites] World J Gastroenterol. 2005 Feb 14;11(6):926-9 [15682496.001]
  • [Cites] Clin Radiol. 1998 Sep;53(9):699-701 [9766725.001]
  • [Cites] Cancer. 1982 Sep 1;50(5):970-81 [7093931.001]
  • [Cites] AJR Am J Roentgenol. 2003 May;180(5):1359-64 [12704052.001]
  • [Cites] Magn Reson Imaging Clin N Am. 1997 May;5(2):397-413 [9113682.001]
  • (PMID = 18463872.001).
  • [ISSN] 0938-7994
  • [Journal-full-title] European radiology
  • [ISO-abbreviation] Eur Radiol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Germany
  • [Number-of-references] 53
  •  go-up   go-down


85. Thakar A, Bahadur S, Toran KC, Mohanti BK, Julka PK: Analysis of oncological and functional failures following near-total laryngectomy. J Laryngol Otol; 2009 Mar;123(3):327-32
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Carcinoma, Squamous Cell / surgery. Fistula / etiology. Laryngeal Neoplasms / surgery. Laryngectomy / adverse effects. Leiomyosarcoma / surgery. Pharyngeal Diseases / etiology
  • [MeSH-minor] Adult. Aged. Arytenoid Cartilage. Disease-Free Survival. Female. Health Status. Humans. India. Male. Middle Aged. Patient Selection. Prospective Studies. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Fistulas.
  • MedlinePlus Health Information. consumer health - Throat Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18559132.001).
  • [ISSN] 1748-5460
  • [Journal-full-title] The Journal of laryngology and otology
  • [ISO-abbreviation] J Laryngol Otol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


86. Kuhnen C, Helwing M, Rabstein S, Homann HH, Müller KM: [Desmoid-type fibromatosis (aggressive fibromatosis)]. Pathologe; 2005 Mar;26(2):117-26
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Desmoid tumors of 33 adult patients were analysed regarding clinical and morphological aspects (sex, age distribution, site, size, mitotic rate, tumor microvessel density, surgical margins, additional radiotherapy).
  • Differential diagnosis of desmoid-type fibromatosis/aggressive fibromatosis in adulthood include various fibroblastic/myofibroblastic soft tissue tumors such as nodular fasciitis, fibrosarcoma, low-grade fibromyxoid sarcoma, myofibroblastic sarcoma as well as leiomyosarcoma and soft tissue leiomyoma.
  • [MeSH-minor] Adult. Combined Modality Therapy. Female. Humans. Male. Mitosis. Recurrence

  • Genetic Alliance. consumer health - Aggressive Fibromatosis.
  • Genetic Alliance. consumer health - Fibromatosis.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Bone Joint Surg Am. 1991 Jun;73(5):717-25 [2045396.001]
  • [Cites] J Pediatr Surg. 1999 Jul;34(7):1112-4 [10442602.001]
  • [Cites] J Pathol. 1991 Aug;164(4):315-9 [1919869.001]
  • [Cites] Br J Surg. 1995 Apr;82(4):510-4 [7613897.001]
  • [Cites] Arkh Patol. 1976;38(11):39-45 [1016080.001]
  • [Cites] Cancer. 1967 Jul;20(7):1131-40 [6027003.001]
  • [Cites] Verh Dtsch Ges Pathol. 1998;82:75-82 [10095420.001]
  • [Cites] Eur J Cancer. 1996 Dec;32A(14):2474-84 [9059336.001]
  • [Cites] Pathologe. 1998 May;19(3):176-86 [9648142.001]
  • [Cites] Am J Surg Pathol. 2000 Oct;24(10):1353-60 [11023096.001]
  • [Cites] Virchows Arch. 1997 Jun;430(6):445-53 [9230909.001]
  • [Cites] N Engl J Med. 1991 Jan 3;324(1):1-8 [1701519.001]
  • [Cites] Virchows Arch A Pathol Anat Histol. 1975 Dec 31;369(2):155-64 [814705.001]
  • [Cites] Am J Surg Pathol. 1995 Jan;19(1):116-7 [7880253.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1997 Oct 1;39(3):659-65 [9336146.001]
  • (PMID = 15657684.001).
  • [ISSN] 0172-8113
  • [Journal-full-title] Der Pathologe
  • [ISO-abbreviation] Pathologe
  • [Language] ger
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


87. Nunobe S, Sano T, Shimada K, Sakamoto Y, Kosuge T: Surgery including liver resection for metastatic gastrointestinal stromal tumors or gastrointestinal leiomyosarcomas. Jpn J Clin Oncol; 2005 Jun;35(6):338-41
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: In recent years, imatinib mesylate (STI 571), a tyrosine kinase inhibitor, has shown short-term clinical usefulness for gastrointestinal stromal tumor or gastrointestinal leiomyosarcoma (GIST).
  • [MeSH-major] Gastrointestinal Neoplasms / secondary. Gastrointestinal Stromal Tumors / secondary. Hepatectomy / mortality. Leiomyosarcoma / secondary. Liver Neoplasms / secondary
  • [MeSH-minor] Adult. Aged. Esophageal Neoplasms / pathology. Female. Humans. Intestinal Neoplasms / pathology. Male. Middle Aged. Stomach Neoplasms / pathology. Survival Rate

  • Genetic Alliance. consumer health - Gastrointestinal Stromal Tumors.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15928191.001).
  • [ISSN] 0368-2811
  • [Journal-full-title] Japanese journal of clinical oncology
  • [ISO-abbreviation] Jpn. J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Japan
  •  go-up   go-down


88. Tsutsumida A, Yoshida T, Yamamoto Y, Itoh T, Minakawa H, Sugihara T: Management of superficial leiomyosarcoma: a retrospective study of 10 cases. Plast Reconstr Surg; 2005 Jul;116(1):8-12
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Management of superficial leiomyosarcoma: a retrospective study of 10 cases.
  • BACKGROUND: Superficial leiomyosarcoma is a rare soft-tissue tumor.
  • METHODS: Ten patients with superficial leiomyosarcoma treated in our institutes were recalled and scheduled for examination.
  • The authors advocate that surgical treatment of low-grade cutaneous leiomyosarcoma by complete excision with a narrow margin is adequate.
  • For low-grade and early-state subcutaneous or soft-tissue leiomyosarcoma, wide excision with a minimum 2-cm lateral margin and one-tissue barrier deep margin is recommended.
  • [MeSH-major] Facial Neoplasms / surgery. Leiomyosarcoma / surgery. Soft Tissue Neoplasms / surgery
  • [MeSH-minor] Adult. Back. Fatal Outcome. Female. Humans. Lung Neoplasms / surgery. Male. Middle Aged. Neoplasm Recurrence, Local / surgery. Neoplasm Staging. Retrospective Studies

  • Genetic Alliance. consumer health - Leiomyosarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15988239.001).
  • [ISSN] 1529-4242
  • [Journal-full-title] Plastic and reconstructive surgery
  • [ISO-abbreviation] Plast. Reconstr. Surg.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


89. Hosokawa Y, Kishino T, Ono T, Oyama N, Momose H: Two cases of female acute urinary retention caused by an impacted pelvic mass. Int J Urol; 2005 Dec;12(12):1069-70
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Leiomyoma / complications. Leiomyosarcoma / complications. Urinary Retention / etiology. Uterine Neoplasms / complications
  • [MeSH-minor] Acute Disease. Adult. Female. Humans

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Fibroids.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16409615.001).
  • [ISSN] 0919-8172
  • [Journal-full-title] International journal of urology : official journal of the Japanese Urological Association
  • [ISO-abbreviation] Int. J. Urol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Australia
  •  go-up   go-down


90. Bernstein-Molho R, Grisaro D, Soyfer V, Safra T, Merimsky O: Metastatic uterine leiomyosarcomas: a single-institution experience. Int J Gynecol Cancer; 2010 Feb;20(2):255-60
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Uterine leiomyosarcoma (LMS) is a rare disease and, when it recurs or metastasizes, can rarely be cured.
  • [MeSH-major] Leiomyosarcoma / mortality. Neoplasm Recurrence, Local / mortality. Uterine Neoplasms / mortality
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Female. Humans. Israel / epidemiology. Middle Aged. Retrospective Studies. Uterus / pathology

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20134269.001).
  • [ISSN] 1525-1438
  • [Journal-full-title] International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
  • [ISO-abbreviation] Int. J. Gynecol. Cancer
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


91. Auerbach A, Fanburg-Smith JC, Wang G, Rushing EJ: Focal myositis: a clinicopathologic study of 115 cases of an intramuscular mass-like reactive process. Am J Surg Pathol; 2009 Jul;33(7):1016-24
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Clinical diagnostic considerations ranged from benign entities such as rhabdomyoma, intramuscular lipoma, fibromatosis, myositis ossificans, proliferative myositis, inflammatory myofibroblastic tumor, and inflammatory myopathy to malignant entities such as rhabdomyosarcoma, leiomyosarcoma, liposarcoma, and lymphoma.
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Child. Female. Genes, T-Cell Receptor. Humans. Immunoglobulin Heavy Chains / genetics. Immunohistochemistry. In Situ Hybridization. Male. Middle Aged. Muscle, Skeletal / pathology. Polymerase Chain Reaction. Young Adult

  • Genetic Alliance. consumer health - Myositis.
  • MedlinePlus Health Information. consumer health - Myositis.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19363438.001).
  • [ISSN] 1532-0979
  • [Journal-full-title] The American journal of surgical pathology
  • [ISO-abbreviation] Am. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Immunoglobulin Heavy Chains
  •  go-up   go-down


92. Erzen D, Sencar M, Novak J: Retroperitoneal sarcoma: 25 years of experience with aggressive surgical treatment at the Institute of Oncology, Ljubljana. J Surg Oncol; 2005 Jul 1;91(1):1-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Retroperitoneal sarcoma: 25 years of experience with aggressive surgical treatment at the Institute of Oncology, Ljubljana.
  • Out of the rest 139 patients, 102 patients had localized retroperitoneal sarcoma, and 37 patients had retroperitoneal sarcoma with distant metastases Leiomyosarcoma was the most common type of histology, followed by liposarcoma and schwannoma.
  • Their referral status was as follow: 56 had primary sarcoma, 20 residual sarcoma after operation elsewhere and 26 already recurrent sarcoma.
  • We removed surgically primary tumor, recurrent sarcoma and metastases, whenever possible.
  • RESULTS: Complete resection was done in 97 of 102 patients with localized sarcoma (resectability rate 95%); in 55 patients, R0 resection was made, in 42 patients, R1 resection, in 3 patients, debulking procedure, and in 2 patients biopsy alone.
  • The 5-, 10-, and 15-year survivals of patients with localized sarcoma were 52%, 36%, and 22%, respectively.
  • The 5-year local recurrence rate of patients with primary sarcoma and of those with locally recurrent sarcoma was 37% and 71%, respectively (P = 0.04).
  • Until there are no other treatment modalities, aggressive surgery for recurrent sarcoma is recommended.
  • [MeSH-major] Neoplasm Recurrence, Local / surgery. Retroperitoneal Neoplasms / surgery. Sarcoma / surgery
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Humans. Male. Middle Aged. Neoplasm Metastasis. Retrospective Studies. Slovenia / epidemiology. Survival Rate

  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15999353.001).
  • [ISSN] 0022-4790
  • [Journal-full-title] Journal of surgical oncology
  • [ISO-abbreviation] J Surg Oncol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


93. Masuzawa N, Kishimoto M, Nishimura A, Ichiba N, Aoki E, Yanagibashi K, Hirota S, Yanagisawa A: Gastric leiomyosarcoma manifesting peculiar findings: radiological-pathological correlation. Pathol Int; 2009 May;59(5):306-11
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Gastric leiomyosarcoma manifesting peculiar findings: radiological-pathological correlation.
  • Reported herein is a gastric leiomyosarcoma, which, nowadays, is extremely rare.
  • Immunoreactivity for several smooth muscle markers including desmin on tumor cells, low amplification of both c-kit and PDGFRA cDNA on polymerase chain reaction, and absence of c-kit gene mutation in exons 9 and 11 strongly suggested that the tumor was not a gastrointestinal stromal tumor but a true leiomyosarcoma.
  • [MeSH-major] Leiomyosarcoma / radiography. Stomach Neoplasms / radiography
  • [MeSH-minor] Adult. Female. Humans. Immunohistochemistry. Magnetic Resonance Imaging. Receptor, Platelet-Derived Growth Factor alpha / genetics. Reverse Transcriptase Polymerase Chain Reaction. Stem Cell Factor / genetics

  • Genetic Alliance. consumer health - Leiomyosarcoma.
  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19432672.001).
  • [ISSN] 1440-1827
  • [Journal-full-title] Pathology international
  • [ISO-abbreviation] Pathol. Int.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Australia
  • [Chemical-registry-number] 0 / Stem Cell Factor; EC 2.7.10.1 / Receptor, Platelet-Derived Growth Factor alpha
  •  go-up   go-down


94. Briese J, Schulte HM, Sajin M, Bamberger C, Redlin K, Milde-Langosch K, Löning T, Bamberger AM: Correlations between reduced expression of the metastasis suppressor gene KAI-1 and accumulation of p53 in uterine carcinomas and sarcomas. Virchows Arch; 2008 Jul;453(1):89-96
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Antigens, CD82 / metabolism. Endometrial Neoplasms / metabolism. Sarcoma / metabolism. Tumor Suppressor Protein p53 / metabolism. Uterine Neoplasms / metabolism
  • [MeSH-minor] Adenocarcinoma, Clear Cell / metabolism. Adenocarcinoma, Clear Cell / pathology. Adult. Aged. Aged, 80 and over. Biomarkers, Tumor / metabolism. Carcinoma, Endometrioid / metabolism. Carcinoma, Endometrioid / pathology. Carcinosarcoma / metabolism. Carcinosarcoma / pathology. Endometrial Hyperplasia / metabolism. Endometrial Hyperplasia / pathology. Female. Gene Expression Regulation, Neoplastic. Humans. Leiomyosarcoma / metabolism. Leiomyosarcoma / pathology. Middle Aged. RNA, Messenger / metabolism. Sarcoma, Endometrial Stromal / metabolism. Sarcoma, Endometrial Stromal / pathology

  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [ErratumIn] Virchows Arch. 2008 Jul;453(1):121
  • [Cites] Gynecol Oncol. 1990 Dec;39(3):364-7 [2258084.001]
  • [Cites] Gynecol Oncol. 2000 Jul;78(1):10-5 [10873402.001]
  • [Cites] Cancer Res. 1996 Apr 15;56(8):1751-5 [8620488.001]
  • [Cites] Immunol Today. 1994 Dec;15(12):588-94 [7531445.001]
  • [Cites] Int J Mol Med. 2004 Oct;14(4):517-27 [15375577.001]
  • [Cites] Horm Res. 2004;62(1):40-8 [15178898.001]
  • [Cites] Cancer Res. 1984 Jun;44(6):2577-81 [6722794.001]
  • [Cites] Am J Pathol. 2007 Jan;170(1):126-39 [17200188.001]
  • [Cites] Cancer Res. 1999 May 15;59(10):2335-9 [10344740.001]
  • [Cites] Cancer Surv. 1991;11:35-42 [1841756.001]
  • [Cites] Virchows Arch. 1999 May;434(5):423-8 [10389625.001]
  • [Cites] Oncogene. 1998 Nov 5;17 (18):2413-7 [9811473.001]
  • [Cites] Cancer Res. 1995 Dec 15;55(24):6040-4 [8521390.001]
  • [Cites] Cancer. 1993 Feb 15;71(4):1368-83 [8435813.001]
  • [Cites] FASEB J. 1997 May;11(6):428-42 [9194523.001]
  • [Cites] Cell. 1997 Feb 7;88(3):323-31 [9039259.001]
  • [Cites] Clin Cancer Res. 2003 Apr;9(4):1393-8 [12684410.001]
  • [Cites] Virchows Arch. 1999 Jan;434(1):23-8 [10071231.001]
  • [Cites] Cell. 1991 Jan 25;64(2):327-36 [1703045.001]
  • [Cites] Cancer Res. 1996 Oct 1;56(19):4387-90 [8813131.001]
  • [Cites] Oncogene. 1999 Dec 13;18(53):7637-43 [10618703.001]
  • [Cites] Cancer Res. 1998 Aug 15;58(16):3526-8 [9721853.001]
  • [Cites] Oncogene. 2005 Jan 20;24(4):637-49 [15580298.001]
  • [Cites] Nucleic Acids Res. 1998 Jan 1;26(1):205-13 [9399837.001]
  • [Cites] Cancer Res. 1992 Mar 15;52(6):1622-7 [1540970.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Sep 15;95(19):11307-11 [9736732.001]
  • [Cites] Science. 1995 May 12;268(5212):884-6 [7754374.001]
  • [Cites] Jpn J Cancer Res. 1998 Apr;89(4):397-404 [9617345.001]
  • [Cites] Virchows Arch. 2004 Mar;444(3):213-23 [14747944.001]
  • [Cites] Gynecol Oncol. 1985 Jun;21(2):135-54 [2985476.001]
  • [Cites] Virchows Arch. 1996 Apr;428(1):47-51 [8646368.001]
  • [Cites] J Clin Endocrinol Metab. 2004 Oct;89(10):5233-44 [15472230.001]
  • [Cites] Hum Pathol. 1998 Oct;29(10):1150-9 [9781657.001]
  • (PMID = 18415123.001).
  • [ISSN] 0945-6317
  • [Journal-full-title] Virchows Archiv : an international journal of pathology
  • [ISO-abbreviation] Virchows Arch.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Antigens, CD82; 0 / Biomarkers, Tumor; 0 / RNA, Messenger; 0 / Tumor Suppressor Protein p53
  •  go-up   go-down


95. Matsuyama A, Hisaoka M, Hashimoto H: Vascular leiomyosarcoma: Clinicopathology and immunohistochemistry with special reference to a unique smooth muscle phenotype. Pathol Int; 2010 Mar;60(3):212-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Vascular leiomyosarcoma: Clinicopathology and immunohistochemistry with special reference to a unique smooth muscle phenotype.
  • Vascular leiomyosarcoma (LMS) is the least frequent type of soft-tissue LMS and has not been fully evaluated immunohistochemically.
  • [MeSH-major] Leiomyosarcoma / pathology. Muscle, Smooth / pathology. Vascular Neoplasms / pathology
  • [MeSH-minor] Adult. Aged. Biomarkers, Tumor / metabolism. Desmin / metabolism. Female. Humans. Immunohistochemistry. Middle Aged

  • Genetic Alliance. consumer health - Leiomyosarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20403047.001).
  • [ISSN] 1440-1827
  • [Journal-full-title] Pathology international
  • [ISO-abbreviation] Pathol. Int.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Australia
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Desmin
  •  go-up   go-down


96. Asoglu O, Porter L, Donohue JH, Cha SS: Laparoscopy for the definitive diagnosis of intra-abdominal lymphoma. Mayo Clin Proc; 2005 May;80(5):625-31
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Of the remaining 25 patients, 7 had nonlymphoma disease (4 occult carcinomas, 1 multiple myeloma, 1 epithelioid leiomyosarcoma, and 1 neuroblastoma), and 18 had benign lymphadenopathy (no evidence of lymphoma with a mean follow-up of 53 months).
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Biopsy / methods. Diagnosis, Differential. False Negative Reactions. Feasibility Studies. Female. Follow-Up Studies. Humans. Laparotomy. Lymphoma, Non-Hodgkin / pathology. Lymphoma, Non-Hodgkin / surgery. Male. Middle Aged. Reproducibility of Results. Retrospective Studies. Safety

  • MedlinePlus Health Information. consumer health - Hodgkin Disease.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15887430.001).
  • [ISSN] 0025-6196
  • [Journal-full-title] Mayo Clinic proceedings
  • [ISO-abbreviation] Mayo Clin. Proc.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


97. West CC, Morritt AN, Pedelty L, Lam DG: Cutaneous leiomyosarcoma arising in a tattoo - 'a tumour with no humour'. J Plast Reconstr Aesthet Surg; 2009 May;62(5):e79-80
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cutaneous leiomyosarcoma arising in a tattoo - 'a tumour with no humour'.
  • [MeSH-major] Leiomyosarcoma / etiology. Skin Neoplasms / etiology. Tattooing / adverse effects
  • [MeSH-minor] Adult. Arm. Humans. Male

  • Genetic Alliance. consumer health - Leiomyosarcoma.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19010751.001).
  • [ISSN] 1878-0539
  • [Journal-full-title] Journal of plastic, reconstructive & aesthetic surgery : JPRAS
  • [ISO-abbreviation] J Plast Reconstr Aesthet Surg
  • [Language] eng
  • [Publication-type] Case Reports; Letter
  • [Publication-country] Netherlands
  •  go-up   go-down


98. Liu FY, Liu XY, Wang Z, Liu Y: [The long-term outcome and prognostic analysis of surgically treated patients with trachea tumors]. Zhonghua Wai Ke Za Zhi; 2009 Jul 15;47(14):1055-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: The histological examination of resected lesions revealed squamous cell carcinoma in 19 cases, adenoid cystic carcinoma in 8 cases, adenocarcinoma in 2 cases, carcinoid in 2 cases, leiomyosarcoma in 1 case and adenoma in 1 case.
  • [MeSH-minor] Adolescent. Adult. Female. Follow-Up Studies. Humans. Male. Middle Aged. Prognosis. Retrospective Studies. Treatment Outcome. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19781267.001).
  • [ISSN] 0529-5815
  • [Journal-full-title] Zhonghua wai ke za zhi [Chinese journal of surgery]
  • [ISO-abbreviation] Zhonghua Wai Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  •  go-up   go-down


99. Koren J, Matecek L, Zamecnik M: Mitotically active deep juvenile xanthogranuloma. Ann Diagn Pathol; 2010 Feb;14(1):36-40
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In the differential diagnosis, we considered especially an atypical diffuse giant cell tumor of tendon sheaths and joints (extra-articular pigmented villonodular synovitis) and some rare types of soft tissue leiomyosarcoma, such as epitheloid leiomyosarcoma and leiomyosarcoma with prominent osteoclast-like giant cells.
  • [MeSH-minor] Adult. Biomarkers. Biopsy, Fine-Needle. Diagnosis, Differential. Female. Giant Cell Tumors / pathology. Humans. Leiomyosarcoma / pathology. Melanoma / pathology. Mitosis. Rhabdomyosarcoma, Alveolar / pathology. Skin Neoplasms / pathology


100. Abatzoglou S, Turcotte RE, Adoubali A, Isler MH, Roberge D: Local recurrence after initial multidisciplinary management of soft tissue sarcoma: is there a way out? Clin Orthop Relat Res; 2010 Nov;468(11):3012-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Local recurrence after initial multidisciplinary management of soft tissue sarcoma: is there a way out?
  • BACKGROUND: Multimodality treatment of primary soft tissue sarcoma by expert teams reportedly affords a low incidence of local recurrence.
  • QUESTIONS/PURPOSES: We (1) determined the incidence of local recurrence from soft tissue sarcoma;.
  • Leiomyosarcoma was the most frequent diagnosis (eight of 37).
  • CONCLUSIONS: Patients with a local recurrence of a soft tissue sarcoma have a poor prognosis.
  • [MeSH-major] Neoplasm Recurrence, Local / surgery. Orthopedic Procedures. Patient Care Team. Sarcoma / surgery. Soft Tissue Neoplasms / surgery
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Amputation. Chi-Square Distribution. Databases as Topic. Female. Humans. Incidence. Kaplan-Meier Estimate. Limb Salvage. Male. Middle Aged. Neoplasm Staging. Quebec. Radiotherapy, Adjuvant. Reoperation. Retrospective Studies. Risk Assessment. Risk Factors. Time Factors. Treatment Outcome. Young Adult

  • Genetic Alliance. consumer health - Soft tissue sarcoma.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Curr Opin Oncol. 2003 Jul;15(4):319-26 [12874511.001]
  • [Cites] Ann Surg. 2003 Feb;237(2):218-26 [12560780.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2003 Nov 1;57(3):739-47 [14529779.001]
  • [Cites] Stat Med. 2003 Nov 30;22(22):3515-25 [14601016.001]
  • [Cites] Ann Surg. 1968 Jul;168(1):47-53 [4299767.001]
  • [Cites] Ann Surg. 1975 Nov;182(5):597-602 [1190864.001]
  • [Cites] Ann Surg. 1982 Jul;196(1):87-91 [7092358.001]
  • [Cites] Radiother Oncol. 1990 Jul;18(3):221-33 [2217870.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1991 Jun;20(6):1229-33 [2045297.001]
  • [Cites] Acta Orthop Scand. 1995 Apr;66(2):147-52 [7740945.001]
  • [Cites] J Clin Oncol. 1996 May;14(5):1679-89 [8622088.001]
  • [Cites] Ann Surg Oncol. 1996 May;3(3):255-60 [8726180.001]
  • [Cites] J Clin Oncol. 1997 Feb;15(2):646-52 [9053489.001]
  • [Cites] Radiother Oncol. 1996 Dec;41(3):209-14 [9027935.001]
  • [Cites] J Bone Joint Surg Br. 1997 Jul;79(4):553-7 [9250737.001]
  • [Cites] Cancer J Sci Am. 1999 Jan-Feb;5(1):26-33 [10188058.001]
  • [Cites] Ann Surg Oncol. 2005 Jan;12(1):10-7 [15827772.001]
  • [Cites] Ann Surg Oncol. 2005 Mar;12(3):228-36 [15827815.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2007 Mar 15;67(4):1124-9 [17208389.001]
  • [Cites] Ann Surg Oncol. 2007 May;14(5):1583-90 [17260106.001]
  • [Cites] Ann Surg Oncol. 2007 May;14(5):1528-9 [17295083.001]
  • [Cites] J Surg Oncol. 2000 Feb;73(2):81-6 [10694643.001]
  • [Cites] Acta Orthop Scand. 2000 Oct;71(5):488-95 [11186407.001]
  • [Cites] Acta Orthop Scand. 2001 Feb;72(1):72-7 [11327418.001]
  • [Cites] Ann Surg Oncol. 2001 May;8(4):278-89 [11352300.001]
  • [Cites] Acta Orthop Scand Suppl. 2001 Feb;72(300):1-31 [11381580.001]
  • [Cites] Lancet. 2002 Jun 29;359(9325):2235-41 [12103287.001]
  • [Cites] Am J Clin Oncol. 2003 Aug;26(4):411-5 [12902897.001]
  • (PMID = 20700676.001).
  • [ISSN] 1528-1132
  • [Journal-full-title] Clinical orthopaedics and related research
  • [ISO-abbreviation] Clin. Orthop. Relat. Res.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC2947683
  •  go-up   go-down






Advertisement